FCCC Faculty Publications

Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, Capitanio U, Porter J, Bertolo R, Minervini A, Lau C, Jacobsohn K, Ashrafi A, Eun D, Mottrie A, White WM, Schips L, Challacombe BJ, De Cobelli O, Mir CM, Veccia A, Larcher A, Kutikov A, Aron M, Dasgupta P, Montorsi F, Gill IS, Sundaram CP, Kaouk J, Derweesh IH. Robotic partial nephrectomy vs minimally invasive radical nephrectomy for clinical T2a renal mass: a propensity score-matched comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. Bju International. .

Smith SM, Wachter K, Burris HA 3rd, Schilsky RL, George DJ, Peterson DE, Johnson ML, Markham MJ, Mileham KF, Beg MS, Bendell JC, Dreicer R, Keedy VL, Kimple RJ, Knoll MA, LoConte N, MacKay H, Meisel JL, Moynihan TJ, Mulrooney DA, Mulvey TM, Odenike O, Pennell NA, Reeder-Hayes K, Smith C, Sullivan RJ, Uzzo R. Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer. J Clin Oncol. 2021 Apr 1;39(10) :1165-1184.

Strother MC, Kutikov A, Epstein M, Bochner E, Deng M, Handorf E, Lewis B, Ghatalia P, Greenberg RE, Chen D, Viterbo R, Anari F, Smaldone MC, Zibelman MR, Uzzo RG, Plimack ER, Geynisman DM. Safety of Neoadjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer and Malignant Ureteral Obstruction. BJU Int. 2021 Mar 29 .

Veccia A, Carbonara U, Derweesh I, Mehrazin R, Porter J, Abdollah F, Mazzone E, Sundaram CP, Gonzalgo M, Mastroianni R, Ghoreifi A, Cacciamani GE, Patel D, Marcus J, Danno A, Steward J, Bhattu AS, Asghar A, Reese AC, Wu Z, Uzzo RG, Minervini A, Rha KH, Ferro M, Margulis V, Hampton LJ, Simone G, Eun DD, Djaladat H, Mottrie A, Autorino R. Single stage Xi® robotic radical nephroureterectomy for upper tract urothelial carcinoma: surgical technique and outcomes. Minerva Urol Nephrol. 2021 Mar 29 .

Correa AF, Jegede OA, Haas NB, Flaherty KT, Pins MR, Adeniran A, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG. Predicting Disease Recurrence, Early Progression, and Overall Survival Following Surgical Resection for High-risk Localized and Locally Advanced Renal Cell Carcinoma. Eur Urol. 2021 Mar 8 .

Zibelman M, Asghar AM, Parker DC, O'Neill J, Wei S, Greenberg RE, Smaldone MC, Chen DYT, Viterbo R, Uzzo RG, Bloom E, Kokate R, Geynisman DM, Ghatalia P, Deng M, Ross EA, Plimack E, Abbosh PH, Kutikov A. Cystoscopy and Systematic Bladder Tissue Sampling in Predicting pT0 Bladder Cancer: A Prospective Trial. J Urol. 2021 Feb 4 :101097ju0000000000001602.

Wu Z, Chen Q, Djaladat H, Minervini A, Uzzo RG, Sundaram CP, Rha KH, Gonzalgo ML, Mehrazin R, Mazzone E, Marcus J, Danno A, Porter J, Asghar A, Ghali F, Guruli G, Douglawi A, Cacciamani G, Ghoreifi A, Simone G, Margulis V, Ferro M, Tellini R, Mari A, Srivastava A, Steward J, Al-Qathani A, Al-Mujalhem A, Bhattu AS, Mottrie A, Abdollah F, Eun DD, Derweesh I, Veccia A, Autorino R, Wang L. A Preoperative Nomogram to Predict Renal Function Insufficiency for Cisplatin-based Adjuvant Chemotherapy Following Minimally Invasive Radical Nephroureterectomy (ROBUUST Collaborative Group). Eur Urol Focus. 2021 Feb 3 .

Ellis JL, Ghiraldi EM, Cohn JA, Nitti M, Friedlander JI, Ginzburg S, Sterious SN, Abbosh P, Ohmann E, Uzzo RG, Simhan J. Prescribing Trends in Post-Operative Pain Management After Urologic Surgery: A Quality Care Investigation for Healthcare Providers. Urology. 2021 Jan 23 .

Cohn JA, Ghiraldi EM, Uzzo RG, Simhan J. A Critical Appraisal of the American College of Surgeons Medically Necessary, Time Sensitive Procedures (MeNTS) Scoring System, Urology Consensus Recommendations and Individual Surgeon Case Prioritization for Resumption of Elective Urological Surgery During the COVID-19 Pandemic. J Urol. 2021 Jan;205(1) :241-247.

Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, Capitanio U, Porter J, Bertolo R, Minervini A, Lau C, Jacobsohn K, Ashrafi A, Eun D, Mottrie A, White WM, Schips L, Challacombe BJ, De Cobelli O, Mir CM, Veccia A, Larcher A, Kutikov A, Aron M, Dasgupta P, Montorsi F, Gill IS, Sundaram CP, Kaouk J, Derweesh IH. Re: Robotic Partial Nephrectomy vs Minimally Invasive Radical Nephrectomy for Clinical T2a Renal Mass: A Propensity Score-Matched Comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. Journal of Urology. 2021 Jan;205(1) :286-286.

Makhov P, Sohn JA, Serebriiskii IG, Fazliyeva R, Khazak V, Boumber Y, Uzzo RG, Kolenko VM. CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma. Br J Cancer. 2020 Dec;123(12) :1749-1756. PMC ID:PMC7723036.

Lucas J, Barlotta R, Brennan M, Leung P, Patel AS, Uzzo RG, Simhan J. Clinical predictors of immediate intervention for isolated renal trauma. Can J Urol. 2020 Dec;27(6) :10456-10460.

Uzzo RN, Drevik J, Panaro J, Geynisman DM. Liquefaction and Rupture of Angiomyolipoma after Embolization. Journal of Vascular and Interventional Radiology. 2020 Dec;31(12) :2051-+.

Patel SH, Uzzo RG, Larcher A, Peyronnet B, Lane BR, Pruthi D, Reddy M, Capitanio U, Joshi S, Noyes S, Eldefrawy A, Ghali F, Meagher MF, Hamilton ZA, Yim K, Nasseri R, Bradshaw AW, Dey S, Kirmiz S, Wan F, Liss MA, Bensalah K, Montorsi F, Derweesh IH. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis. Clin Genitourin Cancer. 2020 Dec;18(6) :e723-e729.

Talwar R, Friel B, Mittal S, Xia L, Fonshell C, Danella J, Jacobs B, Lanchoney T, Raman J, Tomaszewski J, Trabulsi E, Reese A, Singer EA, Ginzburg S, Smaldone M, Uzzo R, Mucksavage P, Guzzo TJ, Lee DJ. Concordance of confirmatory prostate biopsy in active surveillance with national guidelines: An analysis from the multi-institutional PURC cohort. Urol Oncol. 2020 Nov;38(11) :846 e17-846 e22.

Lee DJ, Talwar R, Ding J, Chandrasekar T, Syed K, Fonshell C, Danella J, Ginzburg S, Lanchoney T, Tomaszewski J, Trabulsi E, Reese A, Smaldone M, Uzzo R, Raman JD, Guzzo TJ. Stakeholder Perspective on Opioid Stewardship after Prostatectomy: Evaluating Barriers and Facilitators from the Pennsylvania Urology Regional Collaborative. Urology. 2020 Nov;145 :120-126.

Uzzo RN, Bloom E, Peters A, Parab M, Masic S, Kutikov A. Refractory hypertension due to unilateral renal lymphangiectasia: An uncommon case with a surgical solution. Urol Case Rep. 2020 Sep;32 :101177. PMC ID:PMC7171455.

Geynisman DM, Kadow BT, Shuch BM, Boorjian SA, Matin SF, Rampersaud E, Milestone BN, Plimack ER, Zibelman MR, Kutikov A, Smaldone MC, Chen DY, Viterbo R, Joshi S, Greenberg RE, Malizzia L, McGowan T, Ross EA, Uzzo RG. Reply by Authors. J Urol. 2020 Sep;204(3) :536-537.

Geynisman DM, Kadow BT, Shuch BM, Boorjian SA, Matin SF, Rampersaud E, Milestone BN, Plimack ER, Zibelman MR, Kutikov A, Smaldone MC, Chen DY, Viterbo R, Joshi S, Greenberg RE, Malizzia L, McGowan T, Ross EA, Uzzo RG. Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus (SAGE): Results of a Phase II Trial. J Urol. 2020 Sep;204(3) :531-537. PMC ID:PMC7695484.

Miron B, Hoffman-Censits JH, Anari F, O'Neill J, Geynisman DM, Zibelman MR, Kutikov A, Viterbo R, Greenberg RE, Chen D, Lallas CD, Trabulsi EJ, Alpaugh RK, Dulaimi E, Golemis EA, Uzzo R, Ross EA, Plimack ER. Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer. Eur Urol Oncol. 2020 Aug;3(4) :544-547. PMC ID:PMC7689684.

Cohn JA, Ghiraldi EM, Uzzo RG, Simhan J. A Critical Appraisal of the ACS "Medically-Necessary, Time-Sensitive Procedures" (MeNTS) Scoring System, Urology Consensus Recommendations, and Individual Surgeon Case Prioritization for Resumption of Elective Urologic Surgery During the COVID-19 Pandemic. J Urol. 2020 Jul 27 :101097ju0000000000001315.

Bradshaw AW, Autorino R, Simone G, Yang B, Uzzo RG, Porpiglia F, Capitanio U, Porter J, Bertolo R, Minervini A, Lau C, Jacobsohn K, Ashrafi A, Eun D, Mottrie A, White WM, Schips L, Challacombe BJ, De Cobelli O, Mir CM, Veccia A, Larcher A, Kutikov A, Aron M, Dasgupta P, Montorsi F, Gill IS, Sundaram CP, Kaouk J, Derweesh IH. Robotic Partial Nephrectomy versus Minimally Invasive Radical Nephrectomy for Clinical T2a Renal Mass: A Propensity Score Matched Comparison from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group. BJU Int. 2020 Jul;126(1) :114-123.

Avkshtol V, Ruth KJ, Ross EA, Hallman MA, Greenberg RE, Price RA Jr, Leachman B, Uzzo RG, Ma C, Chen D, Geynisman DM, Sobczak ML, Zhang E, Wong JK, Pollack A, Horwitz EM. Ten-Year Update of a Randomized, Prospective Trial of Conventional Fractionated Versus Moderate Hypofractionated Radiation Therapy for Localized Prostate Cancer. J Clin Oncol. 2020 May 20;38(15) :1676-1684. PMC ID:PMC7238488.

Veccia A, Antonelli A, Uzzo RG, Novara G, Kutikov A, Ficarra V, Simeone C, Mirone V, Hampton LJ, Derweesh I, Porpiglia F, Autorino R. Predictive Value of Nephrometry Scores in Nephron-sparing Surgery: A Systematic Review and Meta-analysis. Eur Urol Focus. 2020 May 15;6(3) :490-504.

Figlin RA, Tannir NM, Uzzo RG, Tykodi SS, Chen DYT, Master V, Kapoor A, Vaena D, Lowrance WT, DeBenedette M, Gamble A, Plachco A, Norris MS, Horvatinovich J, Tcherepanova IY, Nicolette CA, Wood CG. Results of the ADAPT phase 3 study of Rocapuldencel-T in combination with sunitinib as first-line therapy in patients with metastatic renal cell carcinoma. Clin Cancer Res. 2020 May 15;26(10) :2327-2336.

Makhov P, Uzzo RG, Tulin AV, Kolenko VM. Histone-dependent PARP-1 inhibitors: A novel therapeutic modality for the treatment of prostate and renal cancers. Urol Oncol. 2020 May 8 .

Correa AF, Ruth KJ, Al-Saleem T, Pei J, Dulaimi E, Kister D, Collins M, Abbosh PH, Slifker MJ, Ross E, Uzzo RG, Testa JR. Overall tumor genomic instability: an important predictor of recurrence-free survival in patients with localized clear cell renal cell carcinoma. Cancer Biol Ther. 2020 May 3;21(5) :424-431. PMC ID:PMC7515487.

Choueiri TK, Atkins MB, Bakouny Z, Carlo MI, Drake CG, Jonasch E, Kapur P, Lewis B, Linehan WM, Mitchell MJ, Pal SK, Pels K, Poteat S, Rathmell WK, Rini BI, Signoretti S, Tannir N, Uzzo R, Wood CG, Hammers HJ. Summary from the First Kidney Cancer Research Summit, September 12-13, 2019: A Focus on Translational Research. J Natl Cancer Inst. 2020 May 2 .

Markham MJ, Wachter K, Agarwal N, Bertagnolli MM, Chang SM, Dale W, Diefenbach CSM, Rodriguez-Galindo C, George DJ, Gilligan TD, Harvey RD, Johnson ML, Kimple RJ, Knoll MA, LoConte N, Maki RG, Meisel JL, Meyerhardt JA, Pennell NA, Rocque GB, Sabel MS, Schilsky RL, Schneider BJ, Tap WD, Uzzo RG, Westin SN. Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical Oncology. J Clin Oncol. 2020 Apr 1;38(10) :1081.

Lee Z, Jegede OA, Haas NB, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Flaherty KT, Dutcher JP, DiPaola RS, Uzzo RG. Local Recurrence Following Resection of Intermediate-High Risk Nonmetastatic Renal Cell Carcinoma: An Anatomical Classification and Analysis of the ASSURE (ECOG-ACRIN E2805) Adjuvant Trial. J Urol. 2020 Apr;203(4) :684-689. PMC ID:PMC7337326.

Kutikov A, Weinberg DS, Edelman MJ, Horwitz EM, Uzzo RG, Fisher RI. A War on Two Fronts: Cancer Care in the Time of COVID-19. Ann Intern Med. 2020 Mar 27;172(11) :756-758. PMC ID:PMC7133056.

Marchioni M, Berardinelli F, Zhang C, Simone G, Uzzo RG, Capitanio U, Minervini A, Lau C, Kaouk J, Langenstroer P, Amparore D, de Luyk N, Porter J, Gallucci M, Kutikov A, Larcher A, Mari A, Kilday P, Rha KH, Quarto G, Perdonà S, White W, Eun DD, Derweesh I, Mottrie A, Anele UA, Jacobsohn K, Porpiglia F, Challacombe B, Sundaram CP, Autorino R, Yang B, Schips L. Effect of Obesity and Overweight Status on Complications and Survival After Minimally Invasive Kidney Surgery in Patients with Clinical T2-4 Renal Masses. J Endourol. 2020 Mar;34(3) :289-297.

Minervini A, Campi R, Lane BR, De Cobelli O, Sanguedolce F, Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Rodriguez-Faba O, Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M, Karakoyunlu N, Marszalek M, Capitanio U, Volpe A, Brookman-May S, Gschwend JE, Smaldone MC, Uzzo RG, Carini M, Kutikov A. Impact of Resection Technique on Perioperative Outcomes and Surgical Margins after Partial Nephrectomy for Localized Renal Masses: A Prospective Multicenter Study. J Urol. 2020 Mar;203(3) :496-504.

Minervini A, Campi R, Lane BR, De Cobelli O, Sanguedolce F, Hatzichristodoulou G, Antonelli A, Noyes S, Mari A, Rodriguez-Faba O, Keeley FX, Langenhuijsen J, Musi G, Klatte T, Roscigno M, Akdogan B, Furlan M, Karakoyunlu N, Marszalek M, Capitanio U, Volpe A, Brookman-May S, Gschwend JE, Smaldone MC, Uzzo RG, Carini M, Kutikov A. Reply by Authors. J Urol. 2020 Mar;203(3) :503-504.

Pei J, Al-Saleem T, Uzzo RG, Dulaimi E, Testa JR, Wei S. Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-grade Renal Cell Carcinoma With Clear Cell and Papillary Features. Appl Immunohistochem Mol Morphol. 2020 Feb;28(2) :123-129.

Nejati R, Wei S, Uzzo RG, Poureghbali S, Pei J, Talarchek JN, Ruth K, Dulaimi E, Kutikov A, Testa JR, Al-Saleem T. Monosomy of Chromosome 9 Is Associated With Higher Grade, Advanced Stage, and Adverse Outcome in Clear-cell Renal Cell Carcinoma. Clin Genitourin Cancer. 2020 Feb;18(1) :56-61. PMC ID:PMC7781234.

Joshi SS, Handorf ER, Sienko D, Zibelman M, Uzzo RG, Kutikov A, Horwitz EM, Smaldone MC, Geynisman DM. Treatment Facility Volume and Survival in Patients with Advanced Prostate Cancer. Eur Urol Oncol. 2020 Feb;3(1) :104-111. PMC ID:PMC7649050.

Nandanan N, Veccia A, Antonelli A, Derweesh I, Mottrie A, Minervini A, Aron M, Simone G, Capitanio U, Simeone C, Eun D, Perdona S, Porter J, Sundaram C, Zhang C, Uzzo R, Challacombe B, Hampton LJ, Kaouk J, Porpiglia F, Autorino R. Outcomes and predictors of benign histology in patients undergoing robotic partial or radical nephrectomy for renal masses: a multicenter study. Cent European J Urol. 2020 ;73(1) :33-38. PMC ID:PMC7203778.

Cai W, Su L, Liao L, Liu ZZ, Langbein L, Dulaimi E, Testa JR, Uzzo RG, Zhong Z, Jiang W, Yan Q, Zhang Q, Yang H. PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth. Nat Commun. 2019 Dec 20;10(1) :5800. PMC ID:PMC6925188.

Kadow BT, Joshi SS, Kutikov A, Handorf E, Smaldone MC, Uzzo RG, Geynisman DM. The volume-outcome relationship in kidney cancer: is more really better?. Ann Transl Med. 2019 Dec;7(Suppl 8) :S336. PMC ID:PMC6976480.

Agrawal S, Haas NB, Bagheri M, Lane BR, Coleman J, Hammers H, Bratslavsky G, Chauhan C, Kim L, Krishnasamy VP, Marko J, Maher VE, Ibrahim A, Cross F Jr, Liu K, Beaver JA, Pazdur R, Blumenthal GM, Singh H, Plimack ER, Choueiri TK, Uzzo R, Apolo AB. Eligibility and Radiologic Assessment for Adjuvant Clinical Trials in Kidney Cancer. JAMA Oncol. 2019 Nov 21 .

Anele UA, Marchioni M, Yang B, Simone G, Uzzo RG, Lau C, Mir MC, Capitanio U, Porter J, Jacobsohn K, de Luyk N, Mari A, Chang K, Fiori C, Sulek J, Mottrie A, White W, Perdona S, Quarto G, Bindayi A, Ashrafi A, Schips L, Berardinelli F, Zhang C, Gallucci M, Ramirez-Backhaus M, Larcher A, Kilday P, Liao M, Langenstroer P, Dasgupta P, Challacombe B, Kutikov A, Minervini A, Rha KH, Sundaram CP, Hampton LJ, Porpiglia F, Aron M, Derweesh I, Autorino R. Robotic versus laparoscopic radical nephrectomy: a large multi-institutional analysis (ROSULA Collaborative Group). World J Urol. 2019 Nov;37(11) :2439-2450.

Ghatalia P, Gordetsky J, Kuo F, Dulaimi E, Cai KQ, Devarajan K, Bae S, Naik G, Chan TA, Uzzo R, Hakimi AA, Sonpavde G, Plimack E. Correction to: Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma. J Immunother Cancer. 2019 Oct 22;7(1) :273. PMC ID:PMC6806554.

Xu W, Puligandla M, Manola J, Bullock AJ, Tamasauskas D, McDermott DF, Atkins MB, Haas NB, Flaherty K, Uzzo RG, Dutcher JP, DiPaola RS, Bhatt RS. Angiogenic Factor and Cytokine Analysis among Patients Treated with Adjuvant VEGFR TKIs in Resected Renal Cell Carcinoma. Clin Cancer Res. 2019 Oct 15;25(20) :6098-6106. PMC ID:PMC7057142.

Badri AV, Waingankar N, Edwards K, Kutikov A, Parsons RB, Chen DY, Smaldone MC, Viterbo R, Greenberg RE, Uzzo RG. Non-contrast imaging characteristics of papillary renal cell carcinoma: implications for diagnosis and subtyping. Can J Urol. 2019 Oct;26(5) :9916-9921.

Waingankar N, Mallin K, Egleston BL, Winchester DP, Uzzo RG, Kutikov A, Smaldone MC. Trends in Regionalization of Care and Mortality For Patients Treated With Radical Cystectomy. Med Care. 2019 Sep;57(9) :728-733.

Correa AF, Jegede O, Haas NB, Flaherty KT, Pins MR, Messing EM, Manola J, Wood CG, Kane CJ, Jewett MAS, Dutcher JP, DiPaola RS, Carducci MA, Uzzo RG. Predicting Renal Cancer Recurrence: Defining Limitations of Existing Prognostic Models With Prospective Trial-Based Validation. J Clin Oncol. 2019 Aug 10;37(23) :2062-2071.

McIntosh AG, Parker DC, Egleston BL, Uzzo RG, Haseebuddin H, Joshi SS, Viterbo R, Greenberg RE, Chen DYT, Smaldone MC, Kutikov A. Prediction of Significant Estimated Glomerular Filtration Rate Decline Following Renal Unit Removal to Aid in the Clinical Choice between Radical and Partial Nephrectomy in Patients with Renal Mass and Normal Renal Function. BJU Int. 2019 May 30;124(6) :999-1005.

Ghatalia P, Gordetsky J, Kuo F, Dulaimi E, Cai KQ, Devarajan K, Bae S, Naik G, Chan TA, Uzzo R, Hakimi AA, Sonpavde G, Plimack E. Prognostic impact of immune gene expression signature and tumor infiltrating immune cells in localized clear cell renal cell carcinoma. J Immunother Cancer. 2019 May 28;7(1) :139. PMC ID:PMC6540413.

Botejue M, Abbott D, Danella J, Fonshell C, Ginzburg S, Guzzo TJ, Lanchoney T, Marlowe B, Raman JD, Smaldone M, Tomaszewski JJ, Trabulsi EJ, Uzzo RG, Reese AC. Active Surveillance as Initial Management of Newly Diagnosed Prostate Cancer: Data from the PURC. J Urol. 2019 May;201(5) :929-936.

Pei J, Cooper H, Flieder DB, Talarchek JN, Al-Saleem T, Uzzo RG, Dulaimi E, Patchefsky AS, Testa JR, Wei S. NEAT1-TFE3 and KAT6A-TFE3 renal cell carcinomas, new members of MiT family translocation renal cell carcinoma. Mod Pathol. 2019 May;32(5) :710-716. PMC ID:PMC6486435.

Derweesh IH, Staehler M, Uzzo RG. A Return to the Days of Radical Nephrectomy as the "Gold Standard" for Localized Renal Cell Carcinoma? Not So Fast. Eur Urol. 2019 Apr;75(4) :546-547.

Joshi SS, Uzzo RG. Editorial Comment. Urology. 2019 Feb;124 :165-167.

Klingler MJ, Babitz SK, Kutikov A, Campi R, Hatzichristodoulou G, Sanguedolce F, Brookman-May S, Akdogan B, Capitanio U, Roscigno M, Volpe A, Marszalek M, Uzzo RG, Antonelli A, Langenhuijsen J, Carini M, Minervini A, Lane BR. Assessment of volume preservation performed before or after partial nephrectomy accurately predicts postoperative renal function: Results from a prospective multicenter study. Urol Oncol. 2019 Jan;37(1) :33-39.

Correa AF, Uzzo RG. Author Response. Urology. 2019 Jan;123 :179-180.

Narayan V, Puligandla M, Haas NB, Subramanian P, DiPaola RS, Uzzo R. Patterns of Relapse and Implications for Post-Nephrectomy Surveillance in Patients with High Risk Nonclear Cell Renal Cell Carcinoma: Subgroup Analysis of the Phase 3 ECOG-ACRIN E2805 Trial. J Urol. 2019 Jan;201(1) :62-68. PMC ID:PMC6614871.

Psutka SP, Chang SL, Cahn D, Uzzo RG, McGregor BA. Reassessing the Role of Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma in 2019. Am Soc Clin Oncol Educ Book. 2019 Jan;39 :276-283.

Correa AF, Yankey H, Li T, Joshi SS, Kutikov A, Chen DY, Viterbo R, Greenberg RE, Smaldone MC, Uzzo RG. Renal Hilar Lesions: Biological Implications for Complex Partial Nephrectomy. Urology. 2019 Jan;123 :174-180.

Marconi L, de Bruijn R, van Werkhoven E, Beisland C, Fife K, Heidenreich A, Kapoor A, Karam J, Kauffmann C, Klatte T, Ljungberg B, Matin S, Sjoberg D, Staehler M, Stewart GD, Tanguay S, Uzzo R, Welsh S, Wood L, Wood C, Bex A. External validation of a predictive model of survival after cytoreductive nephrectomy for metastatic renal cell carcinoma. World J Urol. 2018 Dec;36(12) :1973-1980.

Edwards DC, Cahn DB, Reddy M, Kivlin D, Malhotra A, Li T, Chen DYT, Viterbo R, Uzzo RG, Greenberg RE, Smaldone MC, Curcillo P, Kutikov A. Incisional hernia after cystectomy: Incidence, risk factors and anthropometric predisposition. Can J Urol. 2018 Dec;25(6) :9573-9578. PMC ID:PMC7569243.

Abbosh P, Sundararajan S, Millis SZ, Hauben A, Reddy S, Geynisman DM, Uzzo R. Molecular and Genomic Profiling to Identify Actionable Targets in Chromophobe Renal Cell Cancer. Eur Urol Focus. 2018 Dec;4(6) :969-971.

Sun M, Marconi L, Eisen T, Escudier B, Giles RH, Haas NB, Harshman LC, Quinn DI, Larkin J, Pal SK, Powles T, Ryan CW, Sternberg CN, Uzzo R, Choueiri TK, Bex A. Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis. Eur Urol. 2018 Nov;74(5) :611-620. PMC ID:PMC7515772.

Goel N, Manstein SM, Ward WH, DeMora L, Smaldone MC, Farma JM, Uzzo RG, Esnaola NF. Does the Surgical Apgar Score predict serious complications after elective major cancer surgery?. J Surg Res. 2018 Nov;231 :242-247.

Shah PH, Alom MA, Leibovich BC, Thompson RH, Uzzo RG, Kavoussi LR, Richstone L, Bhindi B, Habermann EB, Joshi V, Boorjian SA. The Temporal Association of Robotic Surgical Diffusion with Overtreatment of the Small Renal Mass. J Urol. 2018 Nov;200(5) :981-988.

Haas NB, Uzzo RG. Perioperative Therapy in Renal Cell Carcinoma: What Do We Know, What Have We Learned, What's Next?. J Clin Oncol. 2018 Oct 29 :Jco2018789131.

Liao L, Liu ZZ, Langbein L, Cai W, Cho EA, Na J, Niu X, Jiang W, Zhong Z, Cai WL, Jagannathan G, Dulaimi E, Testa JR, Uzzo RG, Wang Y, Stark GR, Sun J, Peiper S, Xu Y, Yan Q, Yang H. Multiple tumor suppressors regulate a HIF-dependent negative feedback loop via ISGF3 in human clear cell renal cancer. Elife. 2018 Oct 25;7 . PMC ID:PMC6234029.

Lee Z, Uzzo R, Asghar A, Parkansky P, Botejue M, Li T, Viterbo R, Chen DY, Smaldone M, Kutikov A. Functional Parenchymal Volume-Based Spectrum Score is Able to Quantify Ischemic Injury after Partial Nephrectomy. Urology. 2018 Oct;120 :150-155.

Ristau BT, Handorf EA, Cahn DB, Kutikov A, Uzzo RG, Smaldone MC. Partial nephrectomy is not associated with an overall survival advantage over radical nephrectomy in elderly patients with stage Ib-II renal masses: An analysis of the national cancer data base. Cancer. 2018 Oct 1;124(19) :3839-3848.

Joshi SS, Handorf EA, Zibelman M, Plimack ER, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM. Treatment Facility Volume and Survival in Patients with Metastatic Renal Cell Carcinoma: A Registry-based Analysis. Eur Urol. 2018 Sep;74(3) :387-393. PMC ID:PMC7548437.

McIntosh AG, Ristau BT, Ruth K, Jennings R, Ross E, Smaldone MC, Chen DYT, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG. Active Surveillance for Localized Renal Masses: Tumor Growth, Delayed Intervention Rates, and >5-yr Clinical Outcomes. Eur Urol. 2018 Aug;74(2) :157-164.

Hamilton ZA, Uzzo RG, Larcher A, Lane BR, Ristau B, Capitanio U, Ryan S, Dey S, Correa A, Reddy M, Proudfoot JA, Nasseri R, Yim K, Noyes S, Bindayi A, Montorsi F, Derweesh IH. Comparison of functional outcomes of robotic and open partial nephrectomy in patients with pre-existing chronic kidney disease: a multicenter study. World J Urol. 2018 Aug;36(8) :1255-1262.

Bertolo R, Autorino R, Simone G, Derweesh I, Garisto JD, Minervini A, Eun D, Perdona S, Porter J, Rha KH, Mottrie A, White WM, Schips L, Yang B, Jacobsohn K, Uzzo RG, Challacombe B, Ferro M, Sulek J, Capitanio U, Anele UA, Tuderti G, Costantini M, Ryan S, Bindayi A, Mari A, Carini M, Keehn A, Quarto G, Liao M, Chang K, Larcher A, De Naeyer G, De Cobelli O, Berardinelli F, Zhang C, Langenstroer P, Kutikov A, Chen D, De Luyk N, Sundaram CP, Montorsi F, Stein RJ, Haber GP, Hampton LJ, Dasgupta P, Gallucci M, Kaouk J, Porpiglia F. Outcomes of Robot-assisted Partial Nephrectomy for Clinical T2 Renal Tumors: A Multicenter Analysis (ROSULA Collaborative Group). Eur Urol. 2018 Aug;74(2) :226-232.

Makhov P, Joshi S, Ghatalia P, Kutikov A, Uzzo RG, Kolenko VM. Resistance to Systemic Therapies in Clear Cell Renal Cell Carcinoma: Mechanisms and Management Strategies. Mol Cancer Ther. 2018 Jul;17(7) :1355-1364. PMC ID:PMC6034114.

Haifler M, Pence I, Sun Y, Kutikov A, Uzzo RG, Mahadevan-Jansen A, Patil CA. Discrimination of malignant and normal kidney tissue with short wave infrared dispersive Raman spectroscopy. J Biophotonics. 2018 Jun;11(6) :e201700188.

Correa AF, Handorf E, Joshi SS, Geynisman DM, Kutikov A, Chen DY, Uzzo RG, Viterbo R, Greenberg RE, Smaldone MC. Differences in Survival Associated with Performance of Lymph Node Dissection in Patients with Invasive Penile Cancer: Results from the National Cancer Database. J Urol. 2018 May;199(5) :1238-1244. PMC ID:PMC7557119.

Anari F, O'Neill J, Choi W, Chen DYT, Haseebuddin M, Kutikov A, Dulaimi E, Alpaugh RK, Devarajan K, Greenberg RE, Bilusic M, Wong YN, Viterbo R, Hoffman-Censits JH, Lallas CD, Trabulsi EJ, Smaldone M, Geynisman DM, Zibelman M, Lin J, Kelly WK, Uzzo R, McConkey D, Plimack ER. Neoadjuvant Dose-dense Gemcitabine and Cisplatin in Muscle-invasive Bladder Cancer: Results of a Phase 2 Trial. Eur Urol Oncol. 2018 May;1(1) :54-60. PMC ID:PMC6226048.

Ristau BT, Chen DYT, Ellis J, Malhotra A, DeMora L, Parsons RB, Milestone B, Brody M, Viterbo R, Greenberg R, Smaldone M, Uzzo R, Anaokar J, Kutikov A. Defining Novel and Practical Metrics to Assess the Deliverables of Multiparametric Magnetic Resonance Imaging/Ultrasound Fusion Prostate Biopsy. J Urol. 2018 Apr;199(4) :969-975. PMC ID:PMC7603901.

Joshi SS, Ruth K, Smaldone MC, Chen DYT, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG. Perioperative Statin Use and Acute Kidney Injury in Patients Undergoing Partial Nephrectomy. Kidney Cancer. 2018 Mar 30;2(1) :47-55. PMC ID:PMC6364048.

Makhov P, Naito S, Haifler M, Kutikov A, Boumber Y, Uzzo RG, Kolenko VM. The convergent roles of NF-kappaB and ER stress in sunitinib-mediated expression of pro-tumorigenic cytokines and refractory phenotype in renal cell carcinoma. Cell Death Dis. 2018 Mar 7;9(3) :374. PMC ID:PMC5841329.

Haifler M, Ristau BT, Higgins AM, Smaldone MC, Kutikov A, Zisman A, Uzzo RG. External Validation of Contact Surface Area as a Predictor of Postoperative Renal Function in Patients Undergoing Partial Nephrectomy. J Urol. 2018 Mar;199(3) :649-654.

Joshi SS, Handorf E, Strauss D, Correa AF, Kutikov A, Chen DYT, Viterbo R, Greenberg RE, Uzzo RG, Smaldone MC, Geynisman DM. Treatment Trends and Outcomes for Patients With Lymph Node-Positive Cancer of the Penis. JAMA Oncol. 2018 Mar 1;4(5) :643-649. PMC ID:PMC5885184.

Dong Y, Zaorsky NG, Li T, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MA, Horwitz EM. Effects of interruptions of external beam radiation therapy on outcomes in patients with prostate cancer. J Med Imaging Radiat Oncol. 2018 Feb;62(1) :116-121. PMC ID:PMC5800942.

Herts BR, Silverman SG, Hindman NM, Uzzo RG, Hartman RP, Israel GM, Baumgarten DA, Berland LL, Pandharipande PV. Management of the Incidental Renal Mass on CT: A White Paper of the ACR Incidental Findings Committee. J Am Coll Radiol. 2018 Feb;15(2) :264-273.

Giri VN, Knudsen KE, Kelly WK, Abida W, Andriole GL, Bangma CH, Bekelman JE, Benson MC, Blanco A, Burnett A, Catalona WJ, Cooney KA, Cooperberg M, Crawford DE, Den RB, Dicker AP, Eggener S, Fleshner N, Freedman ML, Hamdy FC, Hoffman-Censits J, Hurwitz MD, Hyatt C, Isaacs WB, Kane CJ, Kantoff P, Karnes RJ, Karsh LI, Klein EA, Lin DW, Loughlin KR, Lu-Yao G, Malkowicz SB, Mann MJ, Mark JR, McCue PA, Miner MM, Morgan T, Moul JW, Myers RE, Nielsen SM, Obeid E, Pavlovich CP, Peiper SC, Penson DF, Petrylak D, Pettaway CA, Pilarski R, Pinto PA, Poage W, Raj GV, Rebbeck TR, Robson ME, Rosenberg MT, Sandler H, Sartor O, Schaeffer E, Schwartz GF, Shahin MS, Shore ND, Shuch B, Soule HR, Tomlins SA, Trabulsi EJ, Uzzo R, Vander Griend DJ, Walsh PC, Weil CJ, Wender R, Gomella LG. Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017. J Clin Oncol. 2018 Feb 1;36(4) :414-424. PMC ID:PMC6075860.

Ristau BT, Manola J, Haas NB, Heng DYC, Messing EM, Wood CG, Kane CJ, DiPaola RS, Uzzo RG. Retroperitoneal Lymphadenectomy in High-Risk Non-Metastatic Renal Cell Carcinoma: An Analysis of the ASSURE (ECOG-ACRIN 2805) Adjuvant Trial. J Urol. 2018 Jan;199(1) :53-59. PMC ID:PMC5800986.

Mehrazin R, Dulaimi E, Uzzo RG, Devarjan K, Pei J, Smaldone MC, Kutikov A, Testa JR, Al-Saleem T. The correlation between gain of chromosome 8q and survival in patients with clear and papillary renal cell carcinoma. Ther Adv Urol. 2018 Jan;10(1) :3-10. PMC ID:PMC5761913.

Cahn DB, Handorf E, Ristau BT, Geynisman DM, Simhan J, Kutikov A, Greenberg RE, Viterbo R, Chen DYT, Uzzo RG, Smaldone MC. Contemporary practice patterns and survival outcomes for locally advanced urethral malignancies: A National Cancer Database Analysis. Urol Oncol. 2017 Dec;35(12) :670 e15-670 e21.

Minervini A, Campi R, Sessa F, Derweesh I, Kaouk JH, Mari A, Rha KH, Sessa M, Volpe A, Carini M, Uzzo RG. Positive surgical margins and local recurrence after simple enucleation and standard partial nephrectomy for malignant renal tumors: systematic review of the literature and meta-analysis of prevalence. Minerva Urol Nefrol. 2017 Dec;69(6) :523-538.

Parker DC, Handorf E, Smaldone MC, Uzzo RG, Pitt H, Reese AC. Race and postoperative complications following urologic cancer surgery: An ACS-NSQIP analysis. Urol Oncol. 2017 Dec;35(12) :670 e1-670 e6. PMC ID:PMC7682637.

Ramamurthy C, Doyle J, Uzzo RG, Kutikov A, Smaldone MC, Geynisman DM. Role of collaboration between urologists and medical oncologists in the advanced prostate cancer space. Urol Oncol. 2017 Dec;35(12) :665-669.

Cahn DB, Handorf EA, Ghiraldi EM, Ristau BT, Geynisman DM, Churilla TM, Horwitz EM, Sobczak ML, Chen DYT, Viterbo R, Greenberg RE, Kutikov A, Uzzo RG, Smaldone MC. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer. Cancer. 2017 Nov 15;123(22) :4337-4345.

Haas NB, Manola J, Dutcher JP, Flaherty KT, Uzzo RG, Atkins MB, DiPaola RS, Choueiri TK. Adjuvant Treatment for High-Risk Clear Cell Renal Cancer: Updated Results of a High-Risk Subset of the ASSURE Randomized Trial. JAMA Oncol. 2017 Sep 01;3(9) :1249-1252. PMC ID:PMC5591751.

Waingankar N, Mallin K, Smaldone M, Egleston BL, Higgins A, Winchester DP, Uzzo RG, Kutikov A. Assessing the relative influence of hospital and surgeon volume on short-term mortality after radical cystectomy. BJU Int. 2017 Aug;120(2) :239-245. PMC ID:PMC7536895.

Judd J, Zibelman M, Handorf E, O'Neill J, Ramamurthy C, Bentota S, Doyle J, Uzzo RG, Bauman J, Borghaei H, Plimack ER, Mehra R, Geynisman DM. Immune-Related Adverse Events as a Biomarker in Non-Melanoma Patients Treated with Programmed Cell Death 1 Inhibitors. Oncologist. 2017 Jun 26;22(10) :1232-1237. PMC ID:PMC5634771.

Jiang W, Dulaimi E, Devarajan K, Parsons T, Wang Q, O'Neill R, Solomides C, Peiper SC, Testa JR, Uzzo R, Yang H. Intratumoral heterogeneity analysis reveals hidden associations between protein expression losses and patient survival in clear cell renal cell carcinoma. Oncotarget. 2017 Jun 06;8(23) :37423-37434. PMC ID:PMC5514919.

Jung K, Ghatalia P, Litwin S, Horwitz EM, Uzzo RG, Greenberg RE, Viterbo R, Geynisman DM, Kutikov A, Plimack ER, Smaldone MC, Wong YN, Bilusic M. Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. Clin Genitourin Cancer. 2017 Jun;15(3) :E337-E343. PMC ID:PMC7593960.

Waingankar N, Esnaola NF, Uzzo RG. A structured framework for optimizing surgical quality through process-of-care trials. Urol Oncol. 2017 May;35(5) :177-179.

Ristau BT, Correa AF, Uzzo RG, Smaldone MC. Active Surveillance for the Small Renal Mass: Growth Kinetics and Oncologic Outcomes. Urol Clin North Am. 2017 May;44(2) :213-222.

Joshi SS, Uzzo RG. Renal Tumor Anatomic Complexity: Clinical Implications for Urologists. Urol Clin North Am. 2017 May;44(2) :179-187.

Golan S, Johnson SC, Maurice MJ, Kaouk JH, Lai WR, Lee BR, Kheyfets SV, Sundaram CP, Cahn DB, Uzzo RG, Shalhav AL. Safety and early effectiveness of robot-assisted partial nephrectomy for large angiomyolipomas. BJU Int. 2017 May;119(5) :755-760.

McIntosh AG, Li T, Ito T, Mannion J, Dziemianowicz M, Waingankar N, Haseebuddin M, Chen DYT, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG, Smaldone MC, Abbosh PH. WBC Associates with Readmission Following Cystectomy. Bladder Cancer. 2017 Apr 27;3(2) :95-103. PMC ID:PMC5409152.

Naito S, Makhov P, Astsaturov I, Golovine K, Tulin A, Kutikov A, Uzzo RG, Kolenko VM. LDL cholesterol counteracts the antitumour effect of tyrosine kinase inhibitors against renal cell carcinoma. Br J Cancer. 2017 Apr 25;116(9) :1203-1207. PMC ID:PMC5418451.

Lee HO, Uzzo RG, Kister D, Kruger WD. Combination of serum histidine and plasma tryptophan as a potential biomarker to detect clear cell renal cell carcinoma. J Transl Med. 2017 Apr 06;15(1) :72. PMC ID:PMC5383954.

Egleston BL, Uzzo RG, Wong YN. Latent Class Survival Models Linked by Principal Stratification to Investigate Heterogenous Survival Subgroups Among Individuals With Early-Stage Kidney Cancer. J Am Stat Assoc. 2017 Apr;112(518) :534-546. PMC ID:PMC5615848.

Smaldone MC, Egleston B, Hollingsworth JM, Hollenbeck BK, Miller DC, Morgan TM, Kim SP, Malhotra A, Handorf E, Wong YN, Uzzo RG, Kutikov A. Understanding Treatment Disconnect and Mortality Trends in Renal Cell Carcinoma Using Tumor Registry Data. Med Care. 2017 Apr;55(4) :398-404. PMC ID:PMC5352513.

Shaikh T, Li T, Handorf EA, Johnson ME, Wang LS, Hallman MA, Greenberg RE, Price RA Jr, Uzzo RG, Ma C, Chen D, Geynisman DM, Pollack A, Horwitz EM. Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4) :722-731. PMC ID:PMC5331910.

Peri S, Caretti E, Tricarico R, Devarajan K, Cheung M, Sementino E, Menges CW, Nicolas E, Vanderveer LA, Howard S, Conrad P, Crowell JA, Campbell KS, Ross EA, Godwin AK, Yeung AT, Clapper ML, Uzzo RG, Henske EP, Ricketts CJ, Vocke CD, Marston Linehan W, Testa JR, Bellacosa A, Kopelovich L, Knudson AG. Haploinsufficiency in tumor predisposition syndromes: Altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation. Oncotarget. 2017 Mar 14;8(11) :17628-17642. PMC ID:PMC5392274.

Campbell SC, Dong W, Uzzo R, Kutikov A. Re: Elective Nephron Sparing Surgery Decreases Other Cause Mortality Relative to Radical Nephrectomy Only in Specific Subgroups of Patients with Renal Cell Carcinoma. Eur Urol. 2017 Mar;71(3) :495-495.

Finelli A, Ismaila N, Bro B, Durack J, Eggener S, Evans A, Gill I, Graham D, Huang W, Jewett MA, Latcha S, Lowrance W, Rosner M, Shayegan B, Thompson RH, Uzzo R, Russo P. Management of Small Renal Masses: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2017 Feb 20;35(6) :668-680.

Kutikov A, Uzzo RG, Smaldone MC, Haifler M, Bratslavsky G, Leibovich BC. Reply to Patrick O. Richard, Micheal AS Jewett and Antonio Finelli's Letter to the Editor re: Alexander Kutikov, Marc C. Smaldone, Robert G. Uzzo, Miki Haifler, Gennady Bratslavsky, Bradley C. Leibovich. Renal Mass Biopsy: Always, Sometimes, or Never? Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.04.001. Eur Urol. 2017 Feb;71(2) :E47-E48.

Dong Y, Ruth KJ, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MH, Horwitz EM. The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy. Can J Urol. 2017 Feb;24(1) :8656-8662.

Franco-Barraza J, Francescone R, Luong T, Shah N, Madhani R, Cukierman G, Dulaimi E, Devarajan K, Egleston BL, Nicolas E, Katherine Alpaugh R, Malik R, Uzzo RG, Hoffman JP, Golemis EA, Cukierman E. Matrix-regulated integrin alphavbeta5 maintains alpha5beta1-dependent desmoplastic traits prognostic of neoplastic recurrence. Elife. 2017 Jan 31;6 . PMC ID:PMC5283834.

Ito T, Derweesh IH, Ginzburg S, Abbosh PH, Raheem OA, Mirheydar H, Hamilton Z, Chen DY, Smaldone MC, Greenberg RE, Viterbo R, Kutikov A, Uzzo RG. Perioperative Outcomes Following Partial Nephrectomy Performed on Patients Remaining on Antiplatelet Therapy. J Urol. 2017 Jan;197(1) :31-36.

Shore ND, Dinney C, Uzzo R. The society of urologic oncology clinical trials consortium: A brief history and overview. Rev Urol. 2017 ;19(2) :122-124. PMC ID:PMC5610363.

Ristau BT, Kutikov A, Uzzo RG, Smaldone MC. Active Surveillance for Small Renal Masses: When Less is More. Eur Urol Focus. 2016 Dec 15;2(6) :660-668.

Johnson ME, Zaorsky NG, Martin JM, Ruth K, Greenberg RE, Uzzo RG, Hayes SB, Smaldone MC, Kutikov A, Viterbo R, Chen DY, Hallman MA, Sobczak ML, Horwitz EM. Patient reported outcomes among treatment modalities for prostate cancer. Can J Urol. 2016 Dec;23(6) :8535-8545.

Miron B, Ristau BT, Tomaszewski JJ, Jones J, Milestone B, Wong YN, Uzzo RG, Edmondson D, Scott W, Kutikov A. Biology is Destiny: A Case of Adrenocortical Carcinoma Diagnosed and Resected at Inception in a Patient Under Close Surveillance for Lung Cancer. Urol Case Rep. 2016 Nov;9 :9-11. PMC ID:PMC5011172.

Cahn DB, Ristau BT, Ghiraldi EM, Churilla TM, Geynisman DM, Horwitz EM, Uzzo RG, Smaldone MC. Bladder Preservation Therapy: A Review of the Literature and Future Directions. Urology. 2016 Oct;96 :54-61.

Dong Y, Li T, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MH, Horwitz EM. Effects of Time to Treatment on Biochemical and Clinical Outcomes for Patients With Prostate Cancer Treated With Definitive Radiation. Clin Genitourin Cancer. 2016 Oct;14(5) :e463-e468. PMC ID:PMC7646312.

Jiang W, Dulaimi E, Devarajan K, Parsons T, Wang Q, Liao L, Cho EA, O'Neill R, Solomides C, Peiper SC, Testa JR, Uzzo R, Yang H. Immunohistochemistry Successfully Uncovers Intratumoral Heterogeneity and Widespread Co-Losses of Chromatin Regulators in Clear Cell Renal Cell Carcinoma. PLoS One. 2016 Oct;11(10) :e0164554. PMC ID:PMC5072613.

Cahn DB, Ristau BT, Uzzo RG, Smaldone MC. Morbidity and Mortality of Radical Nephrectomy for Patients With Disseminated Cancer: An Analysis of the National Surgical Quality Improvement Program Database. Urology. 2016 Sep;95 :101-102.

Kutikov A, Smaldone MC, Uzzo RG, Haifler M, Bratslavsky G, Leibovich BC. Renal Mass Biopsy: Always, Sometimes, or Never?. Eur Urol. 2016 Sep;70(3) :403-6.

Haas NB, Manola J, Uzzo RG, Flaherty KT, Wood CG, Kane C, Jewett M, Dutcher JP, Atkins MB, Pins M, Wilding G, Cella D, Wagner L, Matin S, Kuzel TM, Sexton WJ, Wong YN, Choueiri TK, Pili R, Puzanov I, Kohli M, Stadler W, Carducci M, Coomes R, DiPaola RS. Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet. 2016 May 14;387(10032) :2008-16. PMC ID:PMC4878938.

Ledezma RA, Negron E, Paner GP, Rjepaj C, Lascano D, Haseebuddin M, Dangle P, Shalhav AL, Crist H, Raman JD, Joel DeCastro G, Harik L, Paroder M, Uzzo RG, Kutikov A, Eggener SE. Clinically localized type 1 and 2 papillary renal cell carcinomas have similar survival outcomes following surgery. World J Urol. 2016 May;34(5) :687-93.

Campbell SC, Gupta GN, Uzzo RG, Kutikov A. Re: Raj Satkunasivam, Sheaumei Tsai, Sumeet Syan, et al. Robotic Unclamped "Minimal-margin" Partial Nephrectomy: Ongoing Refinement of the Anatomic Zero-ischemia Concept. Eur Urol 2015;68:705-12. Eur Urol. 2016 May;69(5) :e95-6.

Uzzo RG, Horwitz EM, Plimack ER. Fox Chase Cancer Center's Genitourinary Division: a national resource for research, innovation and patient care. Future Oncol. 2016 Apr;12(7) :887-91.

Ito T, Pei J, Dulaimi E, Menges C, Abbosh PH, Smaldone MC, Chen DY, Greenberg RE, Kutikov A, Viterbo R, Uzzo RG, Testa JR. Genomic Copy Number Alterations in Renal Cell Carcinoma with Sarcomatoid Features. J Urol. 2016 Apr;195(4 Pt 1) :852-8. PMC ID:PMC4871784.

Waingankar N, Uzzo RG. Editorial Comment. J Urol. 2016 Mar;195(3) :586-7.

Ristau BT, Cahn D, Uzzo RG, Chapin BF, Smaldone MC. The role of radical prostatectomy in high-risk localized, node-positive and metastatic prostate cancer. Future Oncol. 2016 Mar;12(5) :687-99.

Geynisman DM, Handorf E, Wong YN, Doyle J, Plimack ER, Horwitz EM, Canter DJ, Uzzo RG, Kutikov A, Smaldone MC. Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma. Cancer Med. 2016 Feb;5(2) :192-9. PMC ID:PMC4735777.

Waingankar N, Kutikov A, Uzzo RG. Editorial Comment. Urology. 2016 Jan;87 :111-3.

Waingankar N, Kutikov A, Uzzo RG. Functional Recovery From Extended Warm Ischemia Associated With Partial Nephrectomy EDITORIAL COMMENT. Urology. 2016 Jan;87 :111-113.

Mitin T, George A, Zietman AL, Heney NM, Kaufman DS, Uzzo RG, Dreicer R, Wallace HJ 3rd, Souhami L, Dobelbower MC, Sandler HM, Shipley WU. Long-Term Outcomes Among Patients Who Achieve Complete or Near-Complete Responses After the Induction Phase of Bladder-Preserving Combined-Modality Therapy for Muscle-Invasive Bladder Cancer: A Pooled Analysis of NRG Oncology/RTOG 9906 and 0233. Int J Radiat Oncol Biol Phys. 2016 Jan 1;94(1) :67-74. PMC ID:PMC4690848.

Klatte T, Ficarra V, Gratzke C, Kaouk J, Kutikov A, Macchi V, Mottrie A, Porpiglia F, Porter J, Rogers CG, Russo P, Thompson RH, Uzzo RG, Wood CG, Gill IS. A Literature Review of Renal Surgical Anatomy and Surgical Strategies for Partial Nephrectomy. Eur Urol. 2015 Dec;68(6) :980-92. PMC ID:PMC4994971.

Shaikh T, Handorf EA, Murphy CT, Kutikov A, Uzzo RG, Hallman M, Horwitz EM, Smaldone MC. Contemporary Trends in the Utilization of Radiotherapy in Patients With Renal Cell Carcinoma. Urology. 2015 Dec;86(6) :1165-73.

Parker D, Kutikov A, Uzzo RG, Smaldone MC. Understanding Chronic Kidney Disease of Surgical Versus Medical Origin: The Missing Link to the Partial Versus Radical Nephrectomy Debate?. Eur Urol. 2015 Dec;68(6) :1004-6.

Kalbasi A, Li J, Berman A, Swisher-McClure S, Smaldone M, Uzzo RG, Small DS, Mitra N, Bekelman JE. Dose-Escalated Irradiation and Overall Survival in Men With Nonmetastatic Prostate Cancer. JAMA Oncol. 2015 Oct;1(7) :897-906.

Corcoran AT, Kaffenberger SD, Clark PE, Walton J, Handorf E, Piotrowski Z, Tomaszewski JJ, Ginzburg S, Mehrazin R, Plimack E, Chen DY, Smaldone MC, Uzzo RG, Morgan TM, Kutikov A. Hypoalbuminaemia is associated with mortality in patients undergoing cytoreductive nephrectomy. BJU Int. 2015 Sep;116(3) :351-7.

Mehrazin R, Uzzo RG, Kutikov A, Ruth K, Tomaszewski JJ, Dulaimi E, Ginzburg S, Abbosh PH, Ito T, Corcoran AT, Chen DYT, Smaldone MC, Al-Saleem T. Lymphopenia is an independent predictor of inferior outcome in papillary renal cell carcinoma. Urol Oncol. 2015 Sep;33(9) :388.e19-388.e25. PMC ID:PMC4289664.

Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SM, Polsky D, Armstrong K. Reply to G. Gandaglia et al and K. Lu. J Clin Oncol. 2015 Sep 1;33(25) :2833.

Austin SR, Wong YN, Uzzo RG, Beck JR, Egleston BL. Why Summary Comorbidity Measures Such As the Charlson Comorbidity Index and Elixhauser Score Work. Med Care. 2015 Sep;53(9) :e65-72.

Rini BI, Plimack ER, Takagi T, Elson P, Wood LS, Dreicer R, Gilligan T, Garcia J, Zhang Z, Kaouk J, Krishnamurthi V, Stephenson AJ, Fergany A, Klein EA, Uzzo RG, Chen DY, Campbell SC. A Phase II Study of Pazopanib in Patients with Localized Renal Cell Carcinoma to Optimize Preservation of Renal Parenchyma. J Urol. 2015 Aug;194(2) :297-303.

Egleston BL, Uzzo RG, Beck JR, Wong YN. A Simple Method for Evaluating Within Sample Prognostic Balance Achieved by Published Comorbidity Summary Measures. Health Serv Res. 2015 Aug;50(4) :1179-94.

Ginzburg S, Uzzo R, Walton J, Miller C, Kurz D, Li T, Handorf E, Gor R, Corcoran A, Viterbo R, Chen DY, Greenberg RE, Smaldone MC, Kutikov A. Residual Parenchymal Volume, Not Warm Ischemia Time, Predicts Ultimate Renal Functional Outcomes in Patients Undergoing Partial Nephrectomy. Urology. 2015 Jul 18;86(2) :300-6.

Ito T, Abbosh PH, Mehrazin R, Tomaszewski JJ, Li T, Ginzburg S, Canter DJ, Greenberg RE, Viterbo R, Chen DY, Kutikov A, Smaldone MC, Uzzo RG. Surgical apgar score predicts an increased risk of major complications and death after renal mass excision. J Urol. 2015 Jun;193(6) :1918-1922.

Murphy CT, Heller S, Ruth K, Buyyounouski MK, Weinberg D, Uzzo RG, Plimack E, Kutikov A, Chen DYT, Horwitz EM. Evaluating toxicity from definitive radiation therapy for prostate cancer in men with inflammatory bowel disease: Patient selection and dosimetric parameters with modern treatment techniques. Pract Radiat Oncol. 2015 May-Jun;5(3) :e215-e222.

Golovine K, Makhov P, Naito S, Raiyani H, Tomaszewski J, Mehrazin R, Tulin A, Kutikov A, Uzzo RG, Kolenko VM. Piperlongumine and its analogs down-regulate expression of c-Met in renal cell carcinoma. Cancer Biol Ther. 2015 May;16(5) :743-749. PMC ID:PMC4623021.

Martin JM, Li T, Johnson ME, Murphy CT, Howald AG, Smaldone MC, Kutikov A, Chen DY, Viterbo R, Greenberg RE, Uzzo RG, Horwitz EM. Use of Postprostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Center. J Natl Compr Canc Netw. 2015 May;13(5) :525-30.

Zibelman M, Barth P, Handorf E, Smaldone MC, Kutikov A, Uzzo RG, Bilusic M, Plimack ER, Wong YN, Geynisman DM. A review of interventional clinical trials in renal cell carcinoma: a status report from the ClinicalTrials.gov WebSite. Clin Genitourin Cancer. 2015 Apr;13(2) :142-9.

Mehrazin R, Smaldone MC, Egleston B, Tomaszewski JJ, Concodora CW, Ito TK, Abbosh PH, Chen DYT, Kutikov A, Uzzo RG. Is anatomic complexity associated with renal tumor growth kinetics under active surveillance?. Urologic Oncology: Seminars and Original Investigations. 2015 Apr;33(4) :167.e7-167.e12. PMC ID:PMC4417444.

Smaldone MC, Handorf E, Kim SP, Thompson RH, Costello BA, Corcoran AT, Wong YN, Uzzo RG, Leibovich BC, Kutikov A, Boorjian SA. Temporal trends and factors associated with systemic therapy after cytoreductive nephrectomy: an analysis of the National Cancer Database. J Urol. 2015 Apr;193(4) :1108-13.

Tomaszewski JJ, Uzzo RG, Egleston B, Corcoran AT, Mehrazin R, Geynisman DM, Ridge JA, Veloski C, Kocher N, Smaldone MC, Kutikov A. Coupling of prostate and thyroid cancer diagnoses in the United States. Ann Surg Oncol. 2015 Mar;22(3) :1043-9. PMC ID:PMC4419700.

Bekelman JE, Mitra N, Handorf EA, Uzzo RG, Hahn SA, Polsky D, Armstrong K. Effectiveness of androgen-deprivation therapy and radiotherapy for older men with locally advanced prostate cancer. J Clin Oncol. 2015 Mar 1;33(7) :716-22. PMC ID:PMC4334776.

Tomaszewski JJ, Smaldone MC, Uzzo RG, Kutikov A. Is radical nephrectomy a legitimate therapeutic option in patients with renal masses amenable to nephron-sparing surgery?. BJU Int. 2015 Mar;115(3) :357-63.

Piotrowski Z, Tomaszewski JJ, Hartman AL, Edwards K, Uzzo RG. Renal cell carcinoma and an incidental adrenal lesion: adrenal collision tumors. Urology. 2015 Mar;85(3) :e17-8.

Minervini A, Campi R, Smaldone MC, Uzzo RG, Carini M, Kutikov A. Reply to Vincenzo Ficarra, Vito Palumbo, Afrovita Kungulli and Gianluca Giannarini's letter to the editor re: Andrea Minervini, Marco Carini, Robert G. Uzzo, Riccardo Campi, Marc C. Smaldone, Alexander Kutikov. Standardized reporting of resection technique during nephron-sparing surgery: the surface-intermediate-base margin score. Eur Urol 2014;66:803-5. Eur Urol. 2015 Mar;67(3) :e48-51.

Kutikov A, Smaldone MC, Uzzo RG. Focal therapy for treatment of the small renal mass: Dealer's choice or a therapeutic gamble? [Comment; Editorial]. Eur Urol. 2015 Feb;67(2) :260-261.

Corcoran AT, Handorf E, Canter D, Tomaszewski JJ, Bekelman JE, Kim SP, Uzzo RG, Kutikov A, Smaldone MC. Variation in performance of candidate surgical quality measures for muscle-invasive bladder cancer by hospital type. BJU Int. 2015 Feb;115(2) :230-7.

Haas N, Manola J, Ky B, Flaherty KT, Uzzo RG, Kane CJ, Jewett M, Wood L, Wood CG, Atkins MB, Dutcher JJ, Wilding G, DiPaola R. Effects of adjuvant sorafenib and sunitinib on cardiac function in renal cell carcinoma patients without overt metastases:results from ASSURE, ECOG2805. Clin Cancer Res. 2015 Sept 15;21(18) :4048-54. PMC ID:PMC4573791.

Tomaszewski JJ, Handorf E, Corcoran AT, Wong YN, Mehrazin R, Bekelman JE, Canter D, Kutikov A, Chen DY, Uzzo RG, Smaldone MC. Care transitions between hospitals are associated with treatment delay for patients with muscle invasive bladder cancer. J Urol. 2014 Nov;192(5) :1349-54. PMC ID:PMC4422495.

Mehrazin R, Piotrowski Z, Egleston B, Parker D, Tomaszweski JJ, Smaldone MC, Abbosh PH, Ito T, Bloch P, Iffrig K, Bilusic M, Chen DY, Viterbo R, Greenberg RE, Uzzo RG, Kutikov A. Is extended pharmacologic venous thromboembolism prophylaxis uniformly safe after radical cystectomy?. Urology. 2014 Nov;84(5) :1152-6.

Tomaszewski JJ, Uzzo RG, Kocher N, Li T, Manley B, Mehrazin R, Ito T, Abbosh P, Viterbo R, Chen DY, Greenberg RE, Canter D, Smaldone MC, Kutikov A. Patients with anatomically "simple" renal masses are more likely to be placed on active surveillance than those with anatomically "complex" lesions. Urol Oncol. 2014 Nov;32(8) :1267-71. PMC ID:PMC4258180.

Kalbasi A, Swisher-McClure S, Mitra N, Sunderland R, Smaldone MC, Uzzo RG, Bekelman JE. Low rates of adjuvant radiation in patients with nonmetastatic prostate cancer with high-risk pathologic features. Cancer. 2014 Oct 1;120(19) :3089-96. PMC ID:PMC4277873.

Mehrazin R, Smaldone MC, Kutikov A, Li T, Tomaszewski JJ, Canter DJ, Viterbo R, Greenberg RE, Chen DY, Uzzo RG. Growth kinetics and short-term outcomes of cT1b and cT2 renal masses under active surveillance. J Urol. 2014 Sep;192(3) :659-64.

Tomaszewski JJ, Uzzo RG, Smaldone MC. Heterogeneity and renal mass biopsy: a review of its role and reliability. Cancer Biol Med. 2014 Sep;11(3) :162-72.

Tomaszewski JJ, Smaldone MC, Mehrazin R, Kocher N, Ito T, Abbosh P, Baber J, Kutikov A, Viterbo R, Chen DY, Canter DJ, Uzzo RG. Anatomic complexity quantitated by nephrometry score is associated with prolonged warm ischemia time during robotic partial nephrectomy. Urology. 2014 Aug;84(2) :340-4.

Tomaszewski JJ, Smaldone MC, Cung B, Li T, Mehrazin R, Kutikov A, Canter DJ, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Internal validation of the renal pelvic score: a novel marker of renal pelvic anatomy that predicts urine leak after partial nephrectomy. Urology. 2014 Aug;84(2) :351-7.

Simhan J, Smaldone MC, Egleston BL, Canter D, Sterious SN, Corcoran AT, Ginzburg S, Uzzo RG, Kutikov A. Nephron-sparing management vs radical nephroureterectomy for low- or moderate-grade, low-stage upper tract urothelial carcinoma. BJU Int. 2014 Aug;114(2) :216-20. PMC ID:PMC4486373.

Martin JM, Handorf EA, Kutikov A, Uzzo RG, Bekelman JE, Horwitz EM, Smaldone MC. The rise and fall of prostate brachytherapy: use of brachytherapy for the treatment of localized prostate cancer in the National Cancer Data Base. Cancer. 2014 Jul 15;120(14) :2114-21.

Plimack ER, Hoffman-Censits JH, Viterbo R, Trabulsi EJ, Ross EA, Greenberg RE, Chen DY, Lallas CD, Wong YN, Lin J, Kutikov A, Dotan E, Brennan TA, Palma N, Dulaimi E, Mehrazin R, Boorjian SA, Kelly WK, Uzzo RG, Hudes GR. Accelerated methotrexate, vinblastine, doxorubicin, and cisplatin is safe, effective, and efficient neoadjuvant treatment for muscle-invasive bladder cancer: results of a multicenter phase II study with molecular correlates of response and toxicity. J Clin Oncol. 2014 Jun 20;32(18) :1895-901. PMC ID:PMC4050203.

Chen DY, Uzzo RG, Viterbo R. Thinking beyond surgery in the management of renal cell carcinoma: the risk to die from renal cell carcinoma and competing risks of death. World J Urol. 2014 Jun;32(3) :607-13.

Ibragimova I, Dulaimi E, Slifker MJ, Chen DY, Uzzo RG, Cairns P. A global profile of gene promoter methylation in treatment-naive urothelial cancer. Epigenetics. 2014 May;9(5) :760-73. PMC ID:PMC4063835.

Tomaszewski JJ, Uzzo RG. Editorial comment. Urology. 2014 May;83(5) :1079-80.

Swisher-McClure S, Mitra N, Woo K, Smaldone M, Uzzo R, Bekelman JE. Increasing use of dose-escalated external beam radiation therapy for men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys. 2014 May 1;89(1) :103-12. PMC ID:PMC4049263.

Tomaszewski JJ, Uzzo RG, Kutikov A, Hrebinko K, Mehrazin R, Corcoran A, Ginzburg S, Viterbo R, Chen DY, Greenberg RE, Smaldone MC. Assessing the Burden of Complications After Surgery for Clinically Localized Kidney Cancer by Age and Comorbidity Status. Urology. 2014 Apr;83(4) :843-850. PMC ID:PMC 3972626.

Smaldone MC, Uzzo RG. Editorial comment. Urology. 2014 Apr;83(4) :779.

Macfarlane AWth, Jillab M, Plimack ER, Hudes GR, Uzzo RG, Litwin S, Dulaimi E, Al-Saleem T, Campbell KS. PD-1 Expression on Peripheral Blood Cells Increases with Stage in Renal Cell Carcinoma Patients and Is Rapidly Reduced after Surgical Tumor Resection. Cancer Immunol Res. 2014 Apr;2(4) :320-31. PMC ID:PMC 40073434.

Gowrishankar B, Ibragimova I, Zhou Y, Slifker MJ, Devarajan K, Al-Saleem T, Uzzo RG, Cairns P. MicroRNA expression signatures of stage, grade, and progression in clear cell RCC. Cancer Biol Ther. 2014 Mar 1;15(3) :329-41. PMC ID:PMC3974834.

Makhov P, Golovine K, Teper E, Kutikov A, Mehrazin R, Corcoran A, Tulin A, Uzzo RG, Kolenko VM. Piperlongumine promotes autophagy via inhibition of Akt/mTOR signalling and mediates cancer cell death. Br J Cancer. 2014 Feb 18;110(4) :899-907. PMC ID:PMC3929888.

Ginzburg S, Uzzo R, Al-Saleem T, Dulaimi E, Walton J, Corcoran A, Plimack E, Mehrazin R, Tomaszewski J, Viterbo R, Chen DY, Greenberg R, Smaldone M, Kutikov A. Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy. J Urol. 2014 Feb;191(2) :296-300. PMC ID:PMC4083459.

Ginzburg S, Golovine KV, Makhov PB, Uzzo RG, Kutikov A, Kolenko VM. Piperlongumine inhibits NF-kappaB activity and attenuates aggressive growth characteristics of prostate cancer cells. Prostate. 2014 Feb;74(2) :177-86. PMC ID:PMC4052841.

Pollack A, Walker G, Horwitz EM, Price R, Feigenberg S, Konski AA, Stoyanova R, Movsas B, Greenberg RE, Uzzo RG, Ma C, Buyyounouski MK. Randomized trial of hypofractionated external-beam radiotherapy for prostate cancer. J Clin Oncol. 2013 Nov 1;31(31) :3860-8. PMC ID:PMC 3805927.

Smaldone MC, Simhan J, Kutikov A, Canter DJ, Starkey R, Zhu F, Nielsen ME, Stitzenberg KB, Greenberg RE, Uzzo RG. Trends in regionalization of radical cystectomy in three large northeastern states from 1996 to 2009. Urologic Oncology-Seminars and Original Investigations. 2013 Nov;31(8) :1663-1669.

Tobert CM, Uzzo RG, Wood CG, Lane BR. Adjuvant and neoadjuvant therapy for renal cell carcinoma: A survey of the Society of Urologic Oncology. Urologic Oncology-Seminars and Original Investigations. 2013 Oct;31(7) :1316-1320.

Canter DJ, Mallin K, Uzzo RG, Egleston BL, Simhan J, Walton J, Smaldone MC, Master VA, Bratslaysky G, Kutikov A. Association of tumor size with metastatic potential and survival in patients with adrenocortical carcinoma: an analysis of the National Cancer Database. Canadian Journal of Urology. 2013 Oct;20(5) :6915-6921.

Reyes J, Canter D, Putnam S, Simhan J, Smaldone MC, Kutikov A, Viterbo R, Chen DYT, Uzzo RG. Thermal ablation of the small renal mass: Case selection using the RENAL-Nephrometry Score. Urologic Oncology-Seminars and Original Investigations. 2013 Oct;31(7) :1292-1297.

Sterious S, Simhan J, Uzzo RG, Gershman B, Li T, Devarajan K, Canter D, Walton J, Fogg R, Ginzburg S, Corcoran A, Smaldone MC, Kutikov A. Familiarity and self-reported compliance with American Urological Association best practice recommendations for use of thromboembolic prophylaxis among American Urological Association members. J Urol. 2013 Sep;190(3) :992-8.

Smaldone MC, Uzzo RG. Balancing process and risk: standardizing posttreatment surveillance for renal cell carcinoma [Comment]. J Urol. 2013 Aug;190(2) :417-8.

Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, Scoll B, Boorjian SA, Uzzo RG, Wille M, Eggener SE, Lucas SM, Lotan Y, Shariat SF, Raman JD. Multi-institutional validation of the ability of preoperative hydronephrosis to predict advanced pathologic tumor stage in upper-tract urothelial carcinoma. Urologic Oncology-Seminars and Original Investigations. 2013 Aug;31(6) :904-908.

Mitin T, Hunt D, Shipley WU, Kaufman DS, Uzzo R, Wu CL, Buyyounouski MK, Sandler H, Zietman AL. Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial. Lancet Oncology. 2013 Aug;14(9) :863-872.

Canter D, Egleston B, Wong YN, Smaldone MC, Simhan J, Greenberg RE, Uzzo RG, Kutikov A. Use of radical cystectomy as initial therapy for the treatment of high-grade T1 urothelial carcinoma of the bladder: A SEER database analysis. Urologic Oncology-Seminars and Original Investigations. 2013 Aug;31(6) :866-870.

Corcoran AT, Smaldone MC, Egleston BL, Simhan J, Ginzburg S, Morgan TM, Walton J, Chen DY, Viterbo R, Greenberg RE, Uzzo RG, Kutikov A. Comparison of prostate cancer diagnosis in patients receiving unrelated urological and non-urological cancer care. BJU Int. 2013 Jul;112(2) :161-8.

Townsend NC, Ruth K, Al-Saleem T, Horwitz EM, Sobczak M, Uzzo RG, Viterbo R, Buyyounouski MK. Gleason Scoring at a Comprehensive Cancer Center: What's The Difference?. J Natl Compr Canc Netw. 2013 Jul 1;11(7) :812-9. PMC ID:PMC3894783.

Smaldone MC, Uzzo RG. The Kubler-Ross model, physician distress, and performance reporting. Nature Reviews Urology. 2013 Jul;10(7) :425-428.

Lane BR, Golan S, Eggener S, Tobert CM, Kahnoski RJ, Kutikov A, Smaldone M, Whelan CM, Shalhav A, Uzzo RG. Differential Use of Partial Nephrectomy for Intermediate and High Complexity Tumors May Explain Variability in Reported Utilization Rates. Journal of Urology. 2013 Jun;189(6) :2047-2053.

Sterious SN, Simhan J, Smaldone MC, Tsai KJ, Canter D, Wameedh E, Li TY, Helstrom J, Viterbo R, Chen DYT, Greenberg RE, Kutikov A, Al-Saleem T, Uzzo RG. Is there a benefit to frozen section analysis at the time of partial nephrectomy?. Canadian Journal of Urology. 2013 Jun;20(3) :6778-6784.

Smaldone MC, Corcoran AT, Uzzo RG. Active surveillance of small renal masses. Nature Reviews Urology. 2013 May;10(5) :266-274.

Corcoran AT, Smaldone MC, Kutikov A, Uzzo RG. Addressing the evidence gap-Randomized controlled trials for the surgical management of localized genitourinary tract malignancies. Urologic Oncology-Seminars and Original Investigations. 2013 May;31(4) :393-397.

Corcoran AT, Russo P, Lowrance WT, Asnis-Alibozek A, Libertino JA, Pryma DA, Divgi CR, Uzzo RG. A review of contemporary data on surgically resected renal masses-benign or malignant?. Urology. 2013 Apr;81(4) :707-13.

Kolenko V, Teper E, Kutikov A, Uzzo R. Zinc and zinc transporters in prostate carcinogenesis. Nature Reviews Urology. 2013 Apr;10(4) :219-226. PMC ID:PMC 3702371.

Smaldone MC, Churukanti G, Simhan J, Kim SP, Reyes J, Zhu F, Kutikov A, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Clinical characteristics associated with treatment type for localized renal tumors: implications for practice pattern assessment [editorial comment]. Urology. 2013 Feb;81(2) :269-76.

Saroha S, Uzzo RG, Plimack ER, Ruth K, Al-Saleem T. Lymphopenia is an Independent Predictor of Inferior Outcome in Clear Cell Renal Carcinoma. Journal of Urology. 2013 Feb;189(2) :454-460. PMC ID:PMC3545104.

Sudarshan S, Karam JA, Brugarolas J, Thompson RH, Uzzo R, Rini B, Margulis V, Patard JJ, Escudier B, Linehan WM. Metabolism of Kidney Cancer: From the Lab to Clinical Practice. European Urology. 2013 Feb;63(2) :244-251. PMC ID:PMC 3709870.

Smaldone MC, Uzzo RG. Reply. Urology. 2013 Feb;81(2) :276.

Ibragimova I, Slifker MJ, Maradeo ME, Banumathy G, Dulaimi E, Uzzo RG, Cairns P. Genome-wide promoter methylome of small renal masses. PLoS One. 2013 ;8(10) :e77309. PMC ID:PMC3811999.

Simhan J, Canter DJ, Sterious SN, Smaldone MC, Tsai KJ, Li TY, Viterbo R, Chen DYT, Greenberg RE, Kutikov A, Uzzo RG. Pathological Concordance and Surgical Outcomes of Sporadic Synchronous Unilateral Multifocal Renal Masses Treated with Partial Nephrectomy. Journal of Urology. 2013 Jan;189(1) :43-47.

Golovine KV, Makhov PB, Teper E, Kutikov A, Canter D, Uzzo RG, Kolenko VM. Piperlongumine induces rapid depletion of the androgen receptor in human prostate cancer cells. Prostate. 2013 Jan;73(1) :23-30. PMC ID:PMC3491117.

Kutikov A, Egleston BL, Canter D, Smaldone MC, Wong YN, Uzzo RG. Competing Risks of Death in Patients with Localized Renal Cell Carcinoma: A Comorbidity Based Model. Journal of Urology. 2012 Dec;188(6) :2077-2083.

Smaldone MC, Egleston B, Uzzo RG, Kutikov A. Does partial nephrectomy result in a durable overall survival benefit in the Medicare population?. J Urol. 2012 Dec;188(6) :2089-94.

Kutikov A, Cooperberg MR, Paciorek AT, Uzzo RG, Carroll PR, Boorjian SA. Evaluating prostate cancer mortality and competing risks of death in patients with localized prostate cancer using a comprehensive nomogram. Prostate Cancer Prostatic Dis. 2012 Dec;15(4) :374-9. PMC ID:PMC3815610.

Sterious S, Smaldone MC, Plimack E, Uzzo RG, Canter D, Kutikov A. Prolonged natural progression from localized to symptomatic renal cell carcinoma. Can J Urol. 2012 Dec;19(6) :6578-80.

Crispen PL, Soljic A, Stewart G, Kutikov A, Davenport D, Uzzo RG. Enhancing Renal Tumors in Patients with Prior Normal Abdominal Imaging: Further Insight into the Natural History of Renal Cell Carcinoma. Journal of Urology. 2012 Oct;188(4) :1089-1093. PMC ID:PMC 3815634.

Long CJ, Canter DJ, Smaldone MC, Li TY, Simhan J, Rozenfeld B, Teper E, Chen DYT, Greenberg RE, Viterbo R, Uzzo RG, Kutikov A. Role of tumor location in selecting patients for percutaneous versus surgical cryoablation of renal masses. Canadian Journal of Urology. 2012 Oct;19(5) :6417-6422.

Parsons RB, Canter D, Kutikov A, Uzzo RG. RENAL Nephrometry Scoring System: The Radiologist's Perspective. AJR Am J Roentgenol. 2012 Sep;199(3) :W355-9.

Volpe A, Finelli A, Gill IS, Jewett MAS, Martignoni G, Polascik TJ, Remzi M, Uzzo RG. Rationale for Percutaneous Biopsy and Histologic Characterisation of Renal Tumours. European Urology. 2012 Sep;62(3) :491-504.

Smaldone MC, Kutikov A, Egleston B, Simhan J, Canter DJ, Teper E, Viterbo R, Chen DYT, Greenberg RE, Uzzo RG. Assessing Performance Trends in Laparoscopic Nephrectomy and Nephron-sparing Surgery for Localized Renal Tumors. Urology. 2012 Aug;80(2) :286-291.

Simhan J, Smaldone MC, Canter DJ, Zhu F, Starkey R, Stitzenberg KB, Uzzo RG, Kutikov A. Trends in regionalization of adrenalectomy to higher volume surgical centers. J Urol. 2012 Aug;188(2) :377-82.

Makhov PB, Golovine K, Kutikov A, Teper E, Canter DJ, Simhan J, Uzzo RG, Kolenko VM. Modulation of Akt/mTOR Signaling Overcomes Sunitinib Resistance in Renal and Prostate Cancer Cells. Molecular Cancer Therapeutics. 2012 Jul;11(7) :1510-1517. PMC ID:PMC 3491642.

Simhan J, Smaldone MC, Tsai KJ, Li T, Reyes JM, Canter D, Kutikov A, Chen DY, Greenberg RE, Uzzo RG, Viterbo R. Perioperative outcomes of robotic and open partial nephrectomy for moderately and highly complex renal lesions. J Urol. 2012 Jun;187(6) :2000-4.

Ginzburg S, Uzzo RG, Kutikov A. The role of minimally invasive surgery in multifocal renal cell carcinoma. Curr Urol Rep. 2012 Jun;13(3) :202-10.

Lubbe W, Cohen R, Sharma N, Ruth K, Peters R, Li JS, Buyyounouski M, Kutikov A, Chen D, Uzzo R, Horwitz E. Biochemical and clinical experience with real-time intraoperatively planned permanent prostate brachytherapy. Brachytherapy. 2012 May-Jun;11(3) :209-213.

Makhov P, Golovine K, Canter D, Kutikov A, Simhan J, Corlew MM, Uzzo RG, Kolenko VM. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity. Prostate. 2012 May;72(6) :661-667. PMC ID:PMC3208085.

Long CJ, Canter DJ, Kutikov A, Li TY, Simhan J, Smaldone M, Teper E, Viterbo R, Boorjian SA, Chen DYT, Greenberg RE, Uzzo RG. Partial nephrectomy for renal masses >= 7 cm: technical, oncological and functional outcomes. Bju International. 2012 May;109(10) :1450-1456.

Clements T, Messer JC, Terrell JD, Herman MP, Ng CK, Scherr DS, Scoll B, Boorjian SA, Uzzo RG, Wille M, Eggener SE, Lucas SM, Lotan Y, Shariat SF, Raman JD. High-Grade Ureteroscopic Biopsy Is Associated with Advanced Pathology of Upper-Tract Urothelial Carcinoma Tumors at Definitive Surgical Resection. Journal of Endourology. 2012 Apr;26(4) :398-402.

Homma Y, Kakizaki H, Smith JA Jr, Namiki S, Arai Y, Tomita Y, Uzzo R, Tsuchiya N, Takahashi M, Ichikawa T, Quek ML, Uemura H, Mizokami A, Kakizaki H, Steers WD, Gotoh M, Ogawa T, Chancellor MB, Yamamoto S, Takahashi S, Ichihara K. The 7th American Urological Association and the Japanese Urological Association international affiliate society meeting. Int J Urol. 2012 Apr;19(4) :374-85.

Kutikov A, Rozenfeld B, Egleston BL, Sirohi M, Hwang RW, Uzzo RG. Academic Ranking Score: A Publication-Based Reproducible Metric of Thought Leadership in Urology. European Urology. 2012 Mar;61(3) :435-439. PMC ID:PMC3269521.

Simhan J, Canter D, Teper E, Smaldone MC, Patil N, Patchefsky A, Guttmann MC, Milestone B, Wong YN, Hicks LA, Uzzo RG, Kutikov A. Adrenocortical carcinoma masquerading as a benign adenoma on computed tomography washout study. Urology. 2012 Feb;79(2) :e19-20.

Canter D, Simhan J, Smaldone MC, Lebed B, Tokar JL, Wu KN, Uzzo RG, Gustafson KS, Patchefsky AS, Plimack ER, Hoffman JP, Kutikov A. Clinical Stage T1 micropapillary urothelial carcinoma presenting with metastasis to the pancreas. Urology. 2012 Feb;79(2) :e9-10.

Reyes JM, Smaldone MC, Uzzo RG, Viterbo R. Current status of robot-assisted partial nephrectomy. Curr Urol Rep. 2012 Feb;13(1) :24-37.

Reyes JM, Canter DJ, Sirohi M, Simhan J, Smaldone MC, Teper E, Kutikov A, Chen DYT, Uzzo RG. Delayed proximal ureteric stricture formation after complex partial nephrectomy. Bju International. 2012 Feb;109(4) :539-543.

Smaldone MC, Uzzo RG. Kidney cancer in 2011: objectifying risk for localized renal masses [Review]. Nat Rev Urol. 2012 Feb;9(2) :70-2.

Smaldone MC, Kutikov A, Egleston BL, Canter DJ, Viterbo R, Chen DYT, Jewett MA, Greenberg RE, Uzzo RG. Small renal masses progressing to metastases under active surveillance. Cancer. 2012 Feb;118(4) :997-1006.

Hughes L, Zhu F, Ross E, Gross L, Uzzo RG, Chen DY, Viterbo R, Rebbeck TR, Giri VN. Assessing the clinical role of genetic markers of early-onset prostate cancer among high-risk men enrolled in prostate cancer early detection. Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1) :53-60. PMC ID:PMC3253936.

Teper Ervin, Makhov Peter, Golovine Konstantin, Canter Daniel J, Myers Cynthia B, Kutikov Alexander, Sterious Steven N, Uzzo Robert G, Kolenko Vladimir M. The Effect of 5-Aminolevulinic Acid and Its Derivatives on Protoporphyrin IX Accumulation and Apoptotic Cell Death in Castrate-resistant Prostate Cancer Cells. Urology. 2012 ;80(6) :1391.e1-1391.e7. PMC ID:PMC 3514607.

Stitzenberg KB, Wong YN, Nielsen ME, Egleston BL, Uzzo RG. Trends in radical prostatectomy: centralization, robotics, and access to urologic cancer care. Cancer. 2012 Jan;118(1) :54-62. PMC ID:PMC184376.

Canter D, Simhan J, Wu KN, Uzzo RG, Kutikov A. Intensely positron emission tomography-avid benign adrenal adenoma. Urology. 2011 Dec;78(6) :1307-8.

Makhov PB, Golovine KV, Kutikov A, Canter DJ, Rybko VA, Roshchin DA, Matveev VB, Uzzo RG, Kolenko VM. Reversal of epigenetic silencing of AP-2alpha results in increased zinc uptake in DU-145 and LNCaP prostate cancer cells. Carcinogenesis. 2011 Dec;32(12) :1773-1781. PMC ID:PMC3220607.

Klayton TL, Ruth K, Horwitz EM, Uzzo RG, Kutikov A, Chen DYT, Sobczak M, Buyyounouski MK. Young age under 60 years is not a contraindication to treatment with definitive dose escalated radiotherapy for prostate cancer. Radiotherapy and Oncology. 2011 Dec;101(3) :508-512. PMC ID:PMC3225561.

Smaldone MC, Chen DY, Uzzo RG, Yu M. Molecular imaging of the small renal mass. Urol Oncol. 2011 Nov;29(6) :589-92.

Canter D, Kutikov A, Manley B, Egleston B, Simhan J, Smaldone M, Teper E, Viterbo R, Chen DY, Greenberg RE, Uzzo RG. Utility of the R.E.N.A.L. Nephrometry Scoring System in Objectifying Treatment Decision-making of the Enhancing Renal Mass. Urology. 2011 Nov;78(5) :1089-94.

Smaldone MC, Uzzo RG. Active surveillance: a potential strategy for select patients with small renal masses. Future Oncol. 2011 Oct;7(10) :1133-47.

Canter D, Kutikov A, Uzzo RG. How Chester Alan Arthur 'brightened' from a political spoilsman to a civil service reformer. BJU Int. 2011 Oct;108(8) :1235-7.

Kutikov A, Makhov P, Golovine K, Canter DJ, Sirohi M, Street R, Simhan J, Uzzo RG, Kolenko VM. Interleukin-6: A Potential Biomarker of Resistance to Multitargeted Receptor Tyrosine Kinase Inhibitors in Castration-resistant Prostate Cancer. Urology. 2011 Oct;78(4) :968 e7-968 e11. PMC ID:PMC3190126.

Simhan J, Smaldone MC, Tsai KJ, Canter DJ, Li TY, Kutikov A, Viterbo R, Chen DYT, Greenberg RE, Uzzo RG. Objective Measures of Renal Mass Anatomic Complexity Predict Rates of Major Complications Following Partial Nephrectomy. European Urology. 2011 Oct;60(4) :724-730. PMC ID:PMC3319121.

Mustafa A, Gupta S, Hudes GR, Egleston BL, Uzzo RG, Kruger WD. Serum Amino Acid Levels as a Biomarker for Renal Cell Carcinoma. Journal of Urology. 2011 Oct;186(4) :1206-1212. PMC ID:PMC3180900.

Volpe A, Cadeddu JA, Cestari A, Gill IS, Jewett MAS, Joniau S, Kirkali Z, Marberger M, Patard JJ, Staehler M, Uzzo RG. Contemporary Management of Small Renal Masses. European Urology. 2011 Sep;60(3) :501-515.

Makhov P, Kutikov A, Golovine K, Uzzo RG, Canter DJ, Kolenko VM. Docetaxel-Mediated Apoptosis in Myeloid Progenitor TF-I Cells Is Mitigated by Zinc: Potential Implication for Prostate Cancer Therapy. Prostate. 2011 Sep;71(13) :1413-1419. PMC ID:PMC3106130.

Kutikov A, Mallin K, Canter D, Wong YN, Uzzo RG. Effects of Increased Cross-Sectional Imaging on the Diagnosis and Prognosis of Adrenocortical Carcinoma: Analysis of the National Cancer Database. Journal of Urology. 2011 Sep;186(3) :805-810. PMC ID:PMC3432982.

Fogg R, Kutikov A, Uzzo RG, Canter D. How Hugh Hampton Young's Treatment of President Woodrow Wilson's Urinary Retention and Urosepsis Affected the Resolution of World War I. Journal of Urology. 2011 Sep;186(3) :1153-1156.

Messer J, Shariat SF, Brien JC, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Steinberg G, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. Bju International. 2011 Sep;108(5) :701-705.

Smaldone MC, Fung C, Uzzo RG, Haas NB. Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma. Hematol Oncol Clin North Am. 2011 Aug;25(4) :765-91.

Kutikov A, Smaldone MC, Egleston BL, Manley BJ, Canter DJ, Simhan J, Boorjian SA, Viterbo R, Chen DYT, Greenberg RE, Uzzo RG. Anatomic Features of Enhancing Renal Masses Predict Malignant and High-Grade Pathology: A Preoperative Nomogram Using the RENAL Nephrometry Score. European Urology. 2011 Aug;60(2) :241-248. PMC ID:PMC3124570.

Canter D, Kutikov A, Golovine K, Makhov P, Simhan J, Uzzo RG, Kolenko VM. Are all multi-targeted tyrosine kinase inhibitors created equal? An in vitro study of sunitinib and pazopanib in renal cell carcinoma cell lines. Can J Urol. 2011 Aug;18(4) :5819-25. PMC ID:PMC3182114.

Long CJ, Kutikov A, Canter DJ, Egleston BL, Chen DY, Viterbo R, Boorjian SA, Uzzo RG. Percutaneous vs surgical cryoablation of the small renal mass: is efficacy compromised?. BJU Int. 2011 May;107(9) :1376-80.

Canter D, Kutikov A, Sirohi M, Street R, Viterbo R, Chen DYT, Greenberg RE, Uzzo RG. Prevalence of Baseline Chronic Kidney Disease in Patients Presenting With Solid Renal Tumors. Urology. 2011 Apr;77(4) :781-785. PMC ID:PMC3079293.

Kutikov A, Piotrowski ZJ, Canter DJ, Li T, Chen DY, Viterbo R, Greenberg RE, Boorjian SA, Uzzo RG. Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal. J Urol. 2011 Apr;185(4) :1198-203. PMC ID:PMC3117661.

Lane BR, Russo P, Uzzo RG, Hernandez AV, Boorjian SA, Thompson RH, Fergany AF, Love TE, Campbell SC. Comparison of Cold and Warm Ischemia During Partial Nephrectomy in 660 Solitary Kidneys Reveals Predominant Role of Nonmodifiable Factors in Determining Ultimate Renal Function. Journal of Urology. 2011 Feb;185(2) :421-427.

Giri VN, Ruth K, Hughes L, Uzzo RG, Chen DYT, Boorjian SA, Viterbo R, Rebbeck TR. Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val. Bju International. 2011 Feb;107(3) :466-470. PMC ID:PMC3052292.

Canter D, Viterbo R, Kutikov A, Wong YN, Plimack E, Zhu F, Oblaczynski M, Berberian R, Chen DY, Greenberg RE, Uzzo RG, Boorjian SA. Baseline renal function status limits patient eligibility to receive perioperative chemotherapy for invasive bladder cancer and is minimally affected by radical cystectomy. Urology. 2011 Jan;77(1) :160-5.

Canter D, Long C, Kutikov A, Plimack E, Saad I, Oblaczynski M, Zhu F, Viterbo R, Chen DY, Uzzo RG, Greenberg RE, Boorjian SA. Clinicopathological outcomes after radical cystectomy for clinical T2 urothelial carcinoma: further evidence to support the use of neoadjuvant chemotherapy. BJU Int. 2011 Jan;107(1) :58-62.

Gupta V, Bassi DE, Simons JD, Devarajan K, Al-Saleem T, Uzzo RG, Cukierman E. Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma. PLoS One. 2011 ;6(6) :e21494. PMC ID:PMC3125241.

Chen DY, Uzzo RG. Evaluation and management of the renal mass. Med Clin North Am. 2011 Jan;95(1) :179-89.

Klayton TL, Ruth K, Buyyounouski MK, Uzzo RG, Wong YN, Chen DY, Sobczak M, Peter R, Horwitz EM. PSA Doubling Time Predicts for the Development of Distant Metastases for Patients Who Fail 3DCRT Or IMRT Using the Phoenix Definition. Pract Radiat Oncol. 2011 ;1(4) :235-242. PMC ID:PMC3197783.

Canter D, Canter RJ, Kutikov A, Uzzo RG. Andrew Johnson's rocky medical and political 'calculous'. BJU Int. 2010 Dec;106(11) :1569-71.

Piotrowski Z, Canter DJ, Kutikov A, Al-Saleem T, Pei J, Testa JR, Uzzo RG. Metanephric adenofibroma: robotic partial nephrectomy of a large Wilms' tumor variant. Canadian Journal of Urology. 2010 Aug;17(4) :5309-5312.

Aron M, Gill IS, Boorjian SA, Uzzo RG. Treatment of the 2 to 3 cm renal mass. J Urol. 2010 Aug;184(2) :419-22.

Golovine K, Makhov P, Uzzo RG, Kutikov A, Kaplan DJ, Fox E, Kolenko VM. Cadmium down-regulates expression of XIAP at the post-transcriptional level in prostate cancer cells through an NF-kappa B-independent, proteasome-mediated mechanism - art. no. 183. Molecular Cancer. 2010 Jul;9 :183-183. PMC ID:PMC3044330.

Pei J, Feder MM, Al-Saleem T, Liu Z, Liu A, Hudes GR, Uzzo RG, Testa JR. Combined classical cytogenetics and microarray-based genomic copy number analysis reveal frequent 3;5 rearrangements in clear cell renal cell carcinoma. Genes Chromosomes Cancer. 2010 Jul;49(7) :610-9. PMC ID:PMC2953940.

Brien JC, Shariat SF, Herman MP, Ng CK, Scherr DS, Scoll B, Uzzo RG, Wille M, Eggener SE, Terrell JD, Lucas SM, Lotan Y, Boorjian SA, Raman JD. Preoperative Hydronephrosis, Ureteroscopic Biopsy Grade and Urinary Cytology Can Improve Prediction of Advanced Upper Tract Urothelial Carcinoma. Journal of Urology. 2010 Jul;184(1) :69-73.

Kutikov A, Uzzo RG, Caraway A, Reese CT, Egleston BL, Chen DY, Viterbo R, Greenberg RE, Wong YN, Raman JD, Boorjian SA. Use of systemic therapy and factors affecting survival for patients undergoing cytoreductive nephrectomy. BJU Int. 2010 Jul;106(2) :218-23. PMC ID:PMC2906619.

Campbell SC, Faraday M, Uzzo RG. Small renal mass. N Engl J Med. 2010 Jun 17;362(24) :2334; author reply 2334-5.

Scoll BJ, Uzzo RG, Chen DYT, Boorjian SA, Kutikov A, Manley BJ, Viterbo R. Robot-assisted Partial Nephrectomy: A Large Single-institutional Experience. Urology. 2010 Jun;75(6) :1328-1334.

Sharma NK, Cohen RJ, Eade TN, Buyyounouski MK, Uzzo RG, Li JS, Crawford K, Chen DYT, McNeeley S, Horwitz EM. An intraoperative real-time sleeved seed technique for permanent prostate brachytherapy. Brachytherapy. 2010 Apr-Jun;9(2) :126-130.

Lebed B, Jani SD, Kutikov A, Iffrig K, Uzzo RG. Renal masses herniating into the hilum: technical considerations of the "ball-valve phenomenon" during nephron-sparing surgery. Urology. 2010 Mar;75(3) :707-10. PMC ID:PMC2992985 .

Kutikov A, Uzzo R. Reply. Urology. 2010 Mar;75(3) :711-2.

Kaplan DJ, Boorjian SA, Ruth K, Egleston BL, Chen DY, Viterbo R, Uzzo RG, Buyyounouski MK, Raysor S, Giri VN. Evaluation of the Prostate Cancer Prevention Trial Risk calculator in a high-risk screening population. BJU Int. 2010 Feb;105(3) :334-7. PMC ID:PMC2809782.

Touijer K, Jacqmin D, Kavoussi LR, Montorsi F, Patard JJ, Rogers CG, Russo P, Uzzo RG, Van Poppel H. The Expanding Role of Partial Nephrectomy: A Critical Analysis of Indications, Results, and Complications. European Urology. 2010 Feb;57(2) :214-222.

Kutikov A, Egleston BL, Wong YN, Uzzo RG. Evaluating Overall Survival and Competing Risks of Death in Patients With Localized Renal Cell Carcinoma Using a Comprehensive Nomogram. Journal of Clinical Oncology. 2010 Jan;28(2) :311-317. PMC ID:PMC2815719.

Wong YN, Freedland SJ, Egleston B, Vapiwala N, Uzzo R, Armstrong K. The role of primary androgen deprivation therapy in localized prostate cancer. Eur Urol. 2009 Oct;56(4) :609-16. PMC ID:PMC2791191.

Kutikov A, Uzzo RG. The RENAL Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth. Journal of Urology. 2009 Sep;182(3) :844-853.

Kunkle DA, Kutikov A, Uzzo RG. Management of Small Renal Masses. Seminars in Ultrasound Ct and Mri. 2009 Aug;30(4) :352-358.

Crispen PL, Viterbo R, Boorjian SA, Greenberg RE, Chen DYT, Uzzo RG. Natural History, Growth Kinetics, and Outcomes of Untreated Clinically Localized Renal Tumors Under Active Surveillance. Cancer. 2009 Jul;115(13) :2844-2852. PMC ID:PMC2860784.

Chen DY, Uzzo RG. Optimal management of localized renal cell carcinoma: surgery, ablation, or active surveillance. J Natl Compr Canc Netw. 2009 Jun;7(6) :635-43. PMC ID:PMC2759676.

Boorjian SA, Uzzo RG. The evolving management of small renal masses. Curr Oncol Rep. 2009 May;11(3) :211-7. PMC ID:PMC2864077.

Kutikov A, Kunkle DA, Uzzo RG. Focal therapy for kidney cancer: a systematic review. Curr Opin Urol. 2009 Mar;19(2) :148-53. PMC ID:PMC2779779.

Giri VN, Egleston B, Ruth K, Uzzo RG, Chen DY, Buyyounouski M, Raysor S, Hooker S, Torres JB, Ramike T, Mastalski K, Kim TY, Kittles R. Race, genetic West African ancestry, and prostate cancer prediction by prostate-specific antigen in prospectively screened high-risk men. Cancer Prev Res (Phila Pa). 2009 Mar;2(3) :244-50. PMC ID:PMC2652509.

Makhov P, Golovine K, Uzzo RG, Wuestefeld T, Scoll BJ, Kolenko VM. Transcriptional regulation of the major zinc uptake protein hZip1 in prostate cancer cells. Gene. 2009 Feb 15;431(1-2) :39-46. PMC ID:PMC2741159.

Scoll BJ, Wong YN, Egleston BL, Kunkle DA, Saad IR, Uzzo RG. Age, Tumor Size and Relative Survival of Patients With Localized Renal Cell Carcinoma: A Surveillance, Epidemiology and End Results Analysis. Journal of Urology. 2009 Feb;181(2) :506-511. PMC ID:PMC 2703466.

Rothman J, Egleston B, Wong YN, Iffrig K, Lebovitch S, Uzzo RG. Histopathological Characteristics of Localized Renal Cell Carcinoma Correlate With Tumor Size: A SEER Analysis. Journal of Urology. 2009 Jan;181(1) :29-33. PMC ID:PMC2782573.

Kunkle DA, Uzzo RG. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis. Cancer. 2008 Nov 15;113(10) :2671-80.

Makhov P, Golovine K, Uzzo RG, Rothman J, Crispen PL, Shaw T, Scoll BJ, Kolenko VM. Zinc chelation induces rapid depletion of the X-linked inhibitor of apoptosis and sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Cell Death Differ. 2008 Nov;15(11) :1745-51. PMC ID:PMC2585550.

Golovine K, Uzzo RG, Makhov P, Crispen PL, Kunkle D, Kolenko VM. Depletion of intracellular zinc increases expression of tumorigenic cytokines VEGF, IL-6 and IL-8 in prostate cancer cells via NF-kappaB-dependent pathway. Prostate. 2008 Sep 15;68(13) :1443-9.

Golovine K, Makhov P, Uzzo RG, Shaw T, Kunkle D, Kolenko VM. Overexpression of the Zinc Uptake Transporter hZIP1 Inhibits Nuclear Factor-{kappa}B and Reduces the Malignant Potential of Prostate Cancer Cells In vitro and In vivo. Clinical Cancer Research. 2008 Sep 1;14(17) :5376-84.

Crispen PL, Wong YN, Greenberg RE, Chen DY, Uzzo RG. Predicting growth of solid renal masses under active surveillance. Urol Oncol. 2008 Sep-Oct;26(5) :555-9.

Kaplan DJ, Crispen PL, Greenberg RE, Chen DY, Viterbo R, Buyyounouski MK, Horwitz EM, Uzzo RG. Residual prostate cancer after radiotherapy: a study of radical cystoprostatectomy specimens. Urology. 2008 Sep;72(3) :654-8. PMC ID:PMC2660570.

Rothman J, Crispen PL, Wong YN, Al-Saleem T, Fox E, Uzzo RG. Pathologic concordance of sporadic synchronous bilateral renal masses. Urology. 2008 Jul;72(1) :138-42.

Uzzo RG, Haas NB, Crispen PL, Kolenko VM. Mechanisms of apoptosis resistance and treatment strategies to overcome them in hormone-refractory prostate cancer. Cancer. 2008 Apr 15;112(8) :1660-71.

Kunkle DA, Egleston BL, Uzzo RG. Excise, ablate or observe: the small renal mass dilemma--a meta-analysis and review. J Urol. 2008 Apr;179(4) :1227-33; discussion 1233-4.

Crispen PL, Viterbo R, Fox EB, Greenberg RE, Chen DY, Uzzo RG. Delayed intervention of sporadic renal masses undergoing active surveillance. Cancer. 2008 Mar 1;112(5) :1051-7.

D'Ambrosio David J, Ruth Karen, Horwitz Eric M, Uzzo Robert G, Pollack Alan, Buyyounouski Mark K. How Can Men Destined for Biochemical Failure After Androgen Deprivation and Radiotherapy Be Identified Earlier?. International Journal of Radiation Oncology, Biology, Physics. 2008 ;70(5) :1487-1491.

Uzzo RG. Is CT-guided percutaneous radiofrequency ablation oncologically effective in patients with renal cell carcinoma?. Nat Clin Pract Urol. 2008 Jan;5(1) :18-9.

Abramowitz MC, Li T, Buyyounouski MK, Ross E, Uzzo RG, Pollack A, Horwitz EM. The Phoenix definition of biochemical failure predicts for overall survival in patients with prostate cancer. Cancer. 2008 Jan 1;112(1) :55-60.

Uzzo RG. Is CT-guided percutaneous radiofrequency ablation oncologically effective in patients with renal cell carcinoma?. Nat Clin Pract Urol. 2007 Nov 13 :18-19.

Giri VN, Beebe-Dimmer J, Buyyounouski M, Konski A, Feigenberg SJ, Uzzo RG, Hanks G, Godwin AK, Chen DY, Gordon R, Cescon T, Raysor S, Watkins-Bruner D. Prostate cancer risk assessment program: a 10-year update of cancer detection. J Urol. 2007 Nov;178(5) :1920-4; discussion 1924.

Haas NB, Uzzo RG. Targeted therapies for kidney cancer in urologic practice. Urol Oncol. 2007 Sep-Oct;25(5) :420-32.

Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. Timing of biochemical failure and distant metastatic disease for low-, intermediate-, and high-risk prostate cancer after radiotherapy. Cancer. 2007 Jul 1;110(1) :68-80.

Haas NB, Uzzo RG. Tyrosine kinase inhibitors and anti-angiogenic therapies in kidney cancer. Curr Treat Options Oncol. 2007 Jun;8(3) :211-26.

Crispen PL, Uzzo RG. The natural history of untreated renal masses. BJU Int. 2007 May;99(6) :1203-7.

Kunkle DA, Crispen PL, Li TY, Uzzo RG. Tumor size predicts synchronous metastatic renal cell carcinoma: Implications for surveillance of small renal masses. Journal of Urology. 2007 May;177(5) :1692-1696.

Crispen PL, Uzzo RG, Golovine K, Makhov P, Pollack A, Horwitz EM, Greenberg RE, Kolenko VM. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention. Prostate. 2007 May 1;67(6) :582-90.

Kunkle DA, Crispen PL, Chen DYT, Greenberg RE, Uzzo RG. Enhancing renal masses with zero net growth during active surveillance. Journal of Urology. 2007 Mar;177(3) :849-853.

Morgan PB, Hanlon AL, Horwitz EM, Buyyounouski MK, Uzzo RG, Pollack A. Radiation dose and late failures in prostate cancer. International Journal of Radiation Oncology Biology Physics. 2007 Mar;67(4) :1074-1081.

D'Ambrosio DJ, Hanlon AL, Al-Saleem T, Feigenberg SJ, Horwitz EM, Uzzo RG, Pollack A, Buyyounouski MK. The proportion of prostate biopsy tissue with Gleason pattern 4 or 5 predicts for biochemical and clinical outcome after radiotherapy for prostate cancer. International Journal of Radiation Oncology Biology Physics. 2007 Mar;67(4) :1082-1087.

Kunkle DA, Haas NB, Uzzo RG. Adjuvant therapy for high-risk renal cell carcinoma patients. Curr Urol Rep. 2007 Jan;8(1) :19-30.

Matin SF, Ahrar K, Cadeddu JA, Gervais DA, McGovern FJ, Zagoria RA, Uzzo RG, Haaga J, Resnick MI, Kaouk J, Gill IS. Residual and recurrent disease following renal energy ablative therapy: A multi-institutional study. JOURNAL OF UROLOGY. 2006 Nov;176(5) :1973-1977.

Halbert RJ, Figlin RA, Atkins MB, Bernal M, Hutson TE, Uzzo RG, Bukowski RM, Khan KD, Wood CG, Dubois RW, Peacock S, Apicella C, Andrews L, Tucker K, Bankier A, Daly MB, Hopper JL. Treatment of patients with metastatic renal cell cancer - A RAND appropriateness panel. A discrete choice experiment of preferences for genetic counselling among Jewish women seeking cancer genetics services. Cancer. 2006 Nov;95(10) :1448-1453.

Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg D, Pollack A. A prostate specific antigen (PSA) bounce greater than 1.4 ng/mL Is clinically significant after external beam radiotherapy for prostate cancer. American Journal of Clinical Oncology. 2006 Oct;29(5) :458-62.

Uzzo RG, Crispen PL, Golovine K, Makhov P, Horwitz EM, Kolenko VM. Diverse effects of zinc on NF-{kappa}B and AP-1 transcription factors: implications for prostate cancer progression. Carcinogenesis. 2006 Oct;27(10) :1980-90.

Ibanez de Caceres I, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res. 2006 May 15;66(10) :5021-8.

de Caceres II, Dulaimi E, Hoffman AM, Al-Saleem T, Uzzo RG, Cairns P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. CANCER RESEARCH. 2006 May;66(10) :5021-5028.

Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Konski AA, Movsas B, Greenberg RE, Uzzo RG, Ma CMC, McNeeley SW, Buyyounouski MK, Price RA. Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2006 Feb;64(2) :518-526.

Chawla SN, Crispen PL, Hanlon AL, Greenberg RE, Chen DY, Uzzo RG. The natural history of observed enhancing renal masses: meta-analysis and review of the world literature. Journal of Urology. 2006 Feb;175(2) :425-31.

Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A. Defining biochemical failure after radiotherapy with and without androgen deprivation for prostate cancer. International Journal of Radiation Oncology Biology Physics. 2005 Dec 1;63(5) :1455-1462.

Uzzo RG. Renal cell carcinoma: Urologists in a new era. Journal of Urology. 2005 Nov;174(5) :1723-1724.

Yamaguchi K, Uzzo RG, Pimkina J, Makhov P, Golovine K, Crispen P, Kolenko VM. Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Oncogene. 2005 Sep;24(38) :5868-5877.

Viterbo R, Greenberg RE, Al-Saleem T, Uzzo RG. Prior abdominal surgery and radiation do not complicate the retroperitoneoscopic approach to the kidney or adrenal gland. Journal of Urology. 2005 Aug;174(2) :446-450.

Andrews SF, Horwitz EM, Feigenberg SJ, Eisenberg DF, Hanlon AL, Uzzo RG, Pollack A. Does a delay in external beam radiation therapy after tissue diagnosis affect outcome for men with prostate carcinoma?. Cancer. 2005 Jul 15;104(2) :299-304.

Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg D, Pollack A. Long-term androgen deprivation increases Grade 2 and higher late morbidity in prostate cancer patients treated with three-dimensional conformal radiation therapy. International Journal of Radiation Oncology Biology Physics. 2005 Jun 1;62(2) :397-405.

Uzzo RG. Does pathological stage affect the prognosis for patients with clinically staged T1 renal cell carcinoma?. Nature Clinical Practice Urology. 2005 May;2(5) :212-213.

Feigenberg SJ, Hanlon AL, Horwitz EM, Uzzo RG, Eisenberg DF, Pollack A. What pretreatment prostate-specific antigen level warrants long-term androgen deprivation?. International Journal of Radiation Oncology Biology Physics. 2005 Mar 15;61(4) :1003-1010.

Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A. Role of prostate dose escalation in patients with greater than 15% risk of pelvic lymph node involvement. International Journal of Radiation Oncology Biology Physics. 2005 Mar 1;61(3) :695-701.

Buyyounouski Mark K, Hanlon Alexandra L, Horwitz Eric M, Uzzo Robert G, Pollack Alan. Biochemical failure and the temporal kinetics of prostate-specific antigen after radiation therapy with androgen deprivation. International Journal of Radiation Oncology, Biology, Physics. 2005 ;61(5) :1291-1298.

Manne SL, Ostroff JS, Winkel G, Fox K, Grana G, Miller E, Ross S, Frazier T, Buyyounouski MK, Hanlon AL, Eisenberg DF, Horwitz EM, Feigenberg SJ, Uzzo RG, Pollack A, Morrow M, Chen JQ, Yager JD, Russo J, Bassi DE, Fu J, Lopez de Cicco R, Klein-Szanto AJ, Devlin J, Sherman E, Altomare DA, Vaslet CA, Skele KL, De Rienzo A, Devarajan K, Jhanwar SC, McClatchey AI, Kane AB, Testa JR, Murphy ME, Langer CJ, Mehta MP, Viterbo R, Greenberg RE, Al-Saleem T, Canutescu AA, Dunbrack RL Jr, Serebriiskii IG, Fang R, Latypova E, Hopkins R, Vinson C, Joung JK, Golemis EA. Couple-focused group intervention for women with early stage breast cancer. . J Consult Clin Psychol. 2005 Aug May Sep 15 Sep 1 Jun 15 Jun;73(4) :634-46..

Horwitz EM, Feigenberg SJ, Pollack A, Hanks GE, Uzzo RG. Androgen suppression plus radiation therapy for prostate cancer. JAMA-Journal of the American Medical Association. 2004 Nov 3;292(17) :2084-2085.

Buyyounouski MK, Horwitz EM, Uzzo RG, Price RA, McNeeley SW, Azizi D, Hanlon AL, Milestone BN, Pollack A. The radiation doses to erectile tissues defined with magnetic resonance imaging after intensity-modulated radiation therapy or iodine-125 brachytherapy. International Journal of Radiation Oncology, Biology, Physics. 2004 Aug 1;59(5) :1383-91.

Kramer NM, Horwitz EM, Uzzo RG, Hanlon AL, Hanks GE. Matched-cohort analysis of patients with prostate cancer followed with observation or treated with three-dimensional conformal radiation therapy. Bju International. 2004 Jul;94(1) :59-62.

Al-Saleem T, Cairns P, Dulaimi EA, Feder M, Testa JR, Uzzo RG. The genetics of renal oncocytosis: a possible model for neoplastic progression. Cancer Genetics and Cytogenetics. 2004 Jul;152(1) :23-28.

Mueller TJ, Wu H, Greenberg RE, Hudes G, Topham N, Lessin SR, Uzzo RG. Cutaneous metastases from genitourinary malignancies. Urology. 2004 Jun;63(6) :1021-1026.

Yamaguchi K, Uzzo R, Dulin N, Finke JH, Kolenko V. Renal carcinoma cells undergo apoptosis without oligonucleosomal DNA fragmentation. Biochemical and Biophysical Research Communications. 2004 Jun;318(3) :710-713.

Horwitz EM, Feigenberg SJ, Uzzo RG. The treatment of non-metastatic prostate cancer with external beam radiation therapy. Minerva Urologica e Nefrologica. 2004 Jun;56(2) :173-88.

Uzzo RG, Brown JG, Horwitz EM, Hanlon A, Mazzoni S, Konski A, Greenberg RE, Pollack A, Kolenko V, Watkins-Bruner D. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer. BJU International. 2004 May;93(7) :955-960.

Buyyounouski MK, Horwitz EM, Price RA, Hanlon AL, Uzzo RG, Pollack A. Intensity-modulated radiotherapy with MRI simulation to reduce doses received by erectile tissue during prostate cancer treatment. Int J Radiat Oncol Biol Phys. 2004 Mar 1;58(3) :743-9.

Pollack A, Hanlon AL, Horwitz EM, Feigenberg SJ, Uzzo RG, Hanks GE. Prostate cancer radiotherapy dose response: An update of the fox chase experience. Journal of Urology. 2004 Mar;171(3) :1132-1136.

Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Pollack A. Re: Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: Results from the search database - S.J. Freedland, J.C. Presti, Jr., M.K Terris, C.J. Kane, W.J. Aronson, F. Dorey and C.L. Amling for the SEARCH Database Study Group - J Urol, 169 : 2129-2135, 2003. Journal of Urology. 2004 Mar;171(3) :1246-1247.

Jacob R, Hanlon AL, Horwitz EM, Movsas B, Uzzo RG, Pollack A. The relationship of increasing radiotherapy dose to reduced distant metastases and mortality in men with prostate cancer. Cancer. 2004 Feb;100(3) :538-543.

Dulaimi Essel, Uzzo Robert G, Greenberg Richard E, Al-Saleem Tahseen, Cairns Paul. Detection of Bladder Cancer in Urine by a Tumor Suppressor Gene Hypermethylation Panel. Clinical Cancer Research. 2004 ;10(6) :1887-1893.

Kansas BT, Eddy MJ, Mydlo JH, Uzzo RG. Incidence and management of penetrating renal trauma in patients with multiorgan injury: Extended experience at an inner city trauma center. Journal of Urology. 2004 Part 1 OCT;172(4) :1355-1360.

Dulaimi E, de Caceres II, Uzzo RG, Al-Saleem T, Greenberg RE, Polascik TJ, Babb JS, Grizzle WE, Cairns P. Promoter hypermethylation profile of kidney cancer. Clinical Cancer Research. 2004 Part;10(12) :3972-3979.

Uzzo Robert G, Cairns Paul, Dulin Nickolai, Horwitz Eric M, Pollack Alan, Kolenko Vladimir. Tumor resistance to apoptosis: Mechanisms of evasion and implications for radiation and chemotherapeutic strategies. Cancer Immunotherapy at the Crossroads. 2004 :215-234.

Horwitz EM, Uzzo RG, Miller N, Theodorescu D. Brachytherapy for prostate cancer follow-up and management of treatment failures. Urologic Clinics of North America. 2003 Nov;30(4) :737--50, viii-ix..

Nguyen KH, Horwitz EM, Hanlon AL, Uzzo RG, Pollack A. Does short-term androgen deprivation substitute for radiation dose in the treatment of high-risk prostate cancer?. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2) :377-83.

Pollack A, Hanlon AL, Movsas B, Hanks GE, Uzzo R, Horwitz EM. Biochemical failure as a determinant of distant metastasis and death in prostate cancer treated with radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1) :19-23.

Pollack A, Hanlon A, Horwitz EM, Feigenberg S, Uzzo RG, Price RA. Radiation therapy dose escalation for prostate cancer: a rationale for IMRT. World J Urol. 2003 Sep;21(4) :200-8.

Buyyounouski MK, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE, Pollack A. Positive prostate biopsy laterality and implications for staging. Urology. 2003 Aug;62(2) :298-303.

Uzzo RG, Cairns P, Al-Saleem T, Hudes G, Haas N, Greenberg RE, Kolenko V. The basic biology and immunobiology of renal cell carcinoma: considerations for the clinician. Urol Clin North Am. 2003 Aug;30(3) :423-36.

Diefenbach MA, Hamrick N, Uzzo R, Pollack A, Horwitz E, Greenberg R, Engstrom PF. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer. Journal of Urology. 2003 Jul;170(1) :166-169.

Horwitz EM, Uzzo RG, Hanlon AL, Greenberg RE, Hanks GE, Pollack A. Modifying the American Society for Therapeutic Radiology and Oncology definition of biochemical failure to minimize the influence of backdating in patients with prostate cancer treated with 3-dimensional conformal radiation therapy alone. Journal of Urology. 2003 Jun;169(6) :2153-2157.

Uzzo RG, Pinover WH, Horwitz EM, Parlanti A, Mazzoni S, Raysor S, Mirchandani I, Greenberg RE, Pollack A, Hanks GE, Watkins-Bruner D. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination. Urology. 2003 Apr;61(4) :754-9.

Pinover WH, Horwitz EM, Hanlon AL, Uzzo RG, Hanks GE. Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy. Cancer. 2003 Feb 15;97(4) :1127-33.

Uzzo RG. Best therapies for prostate cancer. Bottom Line/Health.. 2003 Feb;17(2) :11-3.

Horwitz EM, Mitra RK, Uzzo RG, Das IJ, Pinover WH, Hanlon AL, McNeeley SW, Hanks GE. Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants. Radiother Oncol. 2003 Feb;66(2) :173-9.

Uzzo RG. Case in point: urinary incontinence with mild obstructive symptoms. Renal & Urology News. 2003 ;2(3) :12.

Battagli Cristina, Uzzo Robert G, Dulaimi Essel, Ibanez de Caceres Inmaculada, Krassenstein Rachel, Al-Saleem Tahseen, Greenberg Richard E, Cairns Paul. Promoter hypermethylation of tumor suppressor genes in urine from kidney cancer patients. Cancer Research. 2003 ;63(24) :8695-8699.

Uzzo RG, Watkins-Bruner D, Horwitz EM, Konski A, Pollack A, Engstrom PF, Kolenko V. Prostate cancer prevention: strategies and realities. Prostate cancer : science and clinical practice. 2003 :89-99.

Uzzo RG, Cairns P, Leavis P, Dulin N, Horwitz EM, Pollack A, Kolenko V. Tumor resistance to apoptosis: Mechanisms of evasion and implications for radiation and chemotherapeutic strategies. Cancer immunotherapy at the crossroads : how tumors evade immunity and what can be done. 2003 :215-233.

Uzzo RG, Leavis P, Hatch W, Gabai VL, Dulin N, Zvartau N, Kolenko VM. Zinc Inhibits Nuclear Factor-kappaB Activation and Sensitizes Prostate Cancer Cells to Cytotoxic Agents. Clin Cancer Res. 2002 Nov;8(11) :3579-83.

Uzzo RG, Cherullo EE, Myles J, Novick AC. Renal cell carcinoma invading the urinary collecting system: Implications for staging. Journal of Urology. 2002 Jun;167(6) :2392-2396.

Uzzo RG, Novick AC, Goormastic M, Mascha E, Pohl M. Medical versus surgical management of atherosclerotic renal artery stenosis. Transplant Proc. 2002 Mar;34(2) :723-5.

Diefenbach MA, Dorsey J, Uzzo RG, Hanks GE, Greenberg RE, Horwitz E, Newton F, Engstrom PF. Decision-making strategies for patients with localized prostate cancer. Semin Urol Oncol. 2002 Feb;20(1) :55-62.

Uzzo RG, Wei JT. Prostate cancer and the educated consumer. Semin Urol Oncol. 2002 Feb;20(1) :1-2.

Wei JT, Uzzo RG. Shared decision-making strategies for early prostate cancer. Semin Urol Oncol. 2002 Feb;20(1) :74-8.

Uzzo RG, Rayman P, Novick AC. The immunobiology of genitourinary tumors. American Urological Association Update. 2002 ;28(21) :218-224.

Uzzo R, Kolenko V, Finke J, Novik A. Assessment of T-Cell Immune Dysfunction in Patients with Renal Cell Carcinoma. Renal cancer : methods and protocols. 2001 ;53 :361-76.

Uzzo R (373 publications)